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1.0 INTRODUCTION 
1.1 Prevalence of fungal infection in oral cavity 
Candida sp. inhabits various parts of the human system including the epidermis, 
vagina, gastro-intestinal tract, nails and oral cavity (Williams et al., 2011).  The disease 
caused by Candida sp. has become a common disease in the late 19
th
 and 20
th
 century 
and its prevalence is still increasing worldwide as a result of multiple factors which can 
facilitate the conversion of its commensal level to the parasitic level (Samaranayake et 
al., 2009).  According to Scardina et al. (2007), the risk factors that enhance the severity 
of a candidal infection can be found widely in patient with impaired salivary gland, 
drug abusers, high carbohydrate diet, smoking habits and Cushing‟s syndrome.  
Candidal infection can occur in almost all human organs.  However, it is the systemic 
infection that can be much more severe and may lead to mortality.  According to Leroy 
et al. (2009), the mortality rate due to systemic infection of Candida sp. was up to 60% 
and still increasing.  The treatment of candidal infection can be difficult and most of the 
diagnosis can only be achieved by autopsy.  With the current incidence in Europe, there 
has been increasing reports in candidemia of 5-folds within 10 years (Bassetti et al., 
2009).  In a most recent study, candidal infection was also associated in oral cancer, 
burning mouth syndrome, endodontic disease and taste disorder (Williams et al., 2011).   
 
Candida albicans is the main causative agent of oropharyngeal candidiasis.  
Researchers have however found that non-albicans species also contribute significantly 
to the development of oral candidosis (Magaldi et al. 2001).  Cases due to non-albicans 
species are increasing in number and this has raised great concern to the society.   
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In Malaysia, based on a survey in 1999, from a total of 1114 yeasts isolates from 
the University of Malaya Medical Center (UMMC), 1.2% was identified as Candida 
krusei (Ng et al., 1999).   A case-control study among 100 healthy subjects in the 
UMMC by Rasool et al. (2005) had shown a predilection for the Chinese infected by 
Candida sp. while the Indian group was found to be the least infected.  This is an 
indication that the dispersion of Candida sp. may vary between ethnic groups. This is a 
strong indication that the habit and background of each different ethnicity might have 
influence on the dispersion.  Candidal infection is still of a major concern although a 
survey carried out in the Hospital of Kuala Lumpur had shown a decreased in candidal 
isolation in the last four years (HKL, 2011).  Despite this claim however, total isolates 
of Candida albicans was found to increase every year.  
    
1.2 Candida krusei in oral infection 
Candida krusei has been identified as the fifth medically dominant pathogen 
after Candida albicans, Candida glabrata, Candia kefyr and Candida parapsilosis 
(Samaranayake and Samaranayake, 1994).  Together with Candida glabrata, Candida 
krusei were recognized as a common pathogen isolated from the blood stream 
worldwide (up to 25%) (Quindós et al., 2008).  Candida krusei was also classified as an 
important pathogen involved in the escalating serious infections involving 
immunocompromised patients (Samaranayake, 1997; Singh et al., 2002; Hakki et al., 
2006; Pfaller et al., 2008; Quindós et al., 2008).  Candida krusei was associated with 
the increased of nosocomial infection within the last two decades and has remained the 
causative agent of morbidity and mortality in immunocompromised patients (Muñoz et 
al., 2005).   
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In the oral cavity, Candida krusei is known as one of the pathogenic yeasts 
associated with oral candidosis.  It persists in the form of patchy to confluent, whitish 
pseudomembranous lesion.  The site of infection is often composed of epithelial cells, 
yeasts and pseudohyphae.  Oral candidosis associated with Candida krusei has been 
reported to increase widely in adolescent and children infected with oral cancer.  
Compared to Candida glabrata and Candida tropicalis the occurrence of Candida 
krusei in oral cancer patients was found to be higher (Gravina et al., 2007).   
 
Candida krusei is an opportunist with multi-drug resistance and this include 
towards fluconazole, a drug often prescribed for the treatment of candidal infection 
(Samaranayake, 1997; Furlaneto-Maia et al., 2008).  Candida krusei is however still 
susceptible towards flucytosine voriconazole, echinocandins (caspofungin, 
anidulafungin and micafungin) and amphotericin B at least until 2004.  Later studies 
then showed a reducing susceptibility incidence towards Candida krusei in oral 
candidosis as a consequence of heterozygous mutation which had altered the sensitivity 
of the yeast (Pfaller et al., 2004; Pfaller et al., 2008).  In addition, treatment with 
amphotericin B was found to be delayed in Candida krusei compared to Candida 
albicans infections. A higher concentration of amphotericin B was also noted at ≥ 1 
mg/kg of body weight per day in order to eliminate the development of Candida krusei.  
Several reports have also discovered that there is decreasing susceptibility of Candida 
krusei towards caspofungin, anidulafungin and micafungin (Hakki et al, 2006).   
 
Data from a surveillance program in 2001 to 2005 in the Asia-Pacific region has 
reported that, 1.3% of 137,487 isolates of Candida sp. from the Asia-Pacific region was 
found to be Candida krusei (Pfaller et al., 2008).   Malaysia had the highest number of 
candidal isolates out of 8 other countries which include Australia, China, India, 
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Indonesia, South Korea, Taiwan and Thailand.  Malaysia was found to have as high as 
39.54% candidal isolates and out of this candidal population, 1.3% isolates were 
Candida krusei.  A decreasing susceptibility of Candida krusei towards voriconazole 
was also reported compared to Candida albicans.  Based on a worldwide observation, 
strains from the American Latin regions had showed the lowest susceptibility towards 
voriconazole, which contradicts an analysis carried out in the South-East Asean 
countries that about 75% of Candida krusei is still susceptible towards the anti fungal 
agents (Pfaller et al., 2008).   
 
1.3 Rationale of study 
Candida krusei was classified in several studies as an emerging pathogen, 
especially in immunocompromised patients (Merz et al., 1986; Samaranayake, 1997; 
Abbas et al., 2000).  In neutropenic patients, report has shown that an infection by 
Candida krusei can lead to high mortality especially in leukemia patients who are 
receiving fluconazole as prophylaxis (Abbas et al., 2000).  Many therapies using 
fluconazole and also caspofungin were failed in reducing the infection (Fleck et al., 
2007).  This phenomenon has increased the awareness of researchers to focus on the 
virulence factors of Candida krusei in the attempt to reduce the disease caused by the 
pathogen. One of the most important virulent factors of Candida sp. is the ability to 
switch its phenotypic in order to survive in an unfavourable growth environment 
(Haynes, 2001). Thus, it is important to validate the ability of Candida krusei in 
phenotypic switching and adherence.  The understanding on this two characteristics 
shed information on the pathogenicity of Candida krusei in causing candidal infection. 
Candida sp. is also able to adhere firmly to hard surfaces of dentures.  Candidal 
adherence can occur either on the soft tissue such as the buccal and palatal surfaces or 
on the hard tissue surface of dentures (Haynes, 2001).  The ability to attach to hard 
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surfaces is actually the key factor in initiating candidal infections.  In addition, this 
research is also targeted at assessing the antifungal activities of commercialized 
antifungal agents and two plant extracts against Candida krusei.  Nigella sativa and 
Piper betle are two plants frequently used in traditional practices to cure various types 
of illnesses.  A positive antifungal property would enable these plants to be further 
tested for use as antifungal agent. 
 
1.4 Hypothesis of study 
Phenotypic switching affects the biological properties of Candida krusei.  
 
1.5  Aims of study 
The aims of study are: 
1) To determine the phenotypic switching ability of Candida krusei. 
2) To determine the effect of phenotypic switching on the biological properties 
of Candida krusei. 
3) To evaluate the consequences of phenotypic switching on the susceptibility 
towards commercialized antifungal agents and plant extract (Nigella sativa 
and Piper betle). 
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2.0 LITERATURE REVIEW 
2.1 Oral Candida 
2.1.1 Candida as a component of oral ecosystem 
Candida sp. was identified as a common member of the oral microflora and was 
estimated at 40% to 60% of the microbial population in the oral cavity.  It can be 
present either as transient or permanent colonizer in the oral cavity (Mitchell, 2007; 
Thein et al., 2007).  It is also recognised as an opportunistic microorganism that is able 
of causing oral diseases such as oral candidosis (Marsh and Martin, 2009).  
 
2.1.2 Colonization sites 
Candida sp. is identified to colonise several host cell types including epithelial, 
endothelial and phagocytic cells.  In the oral cavity, Candida sp. prefers to colonise 
several surfaces including the buccal and labial mucosa, dorsum or lateral borders of 
tongue, hard and soft palate regions, tooth surfaces and denture-bearing areas (Cannon 
et al., 1995; Siar et al., 2003).  This colonising ability is contributed by factors 
including the ability of the oral candidal species to produce specific enzymes such as 
agglutinin-like proteins and integrin-like protein that lead to the formation of biofilm on 
oral surfaces.  In addition, other factors which influence the colonisation of Candida sp. 
are the reduction of salivary flow, low salivary pH, trauma, carbohydrate-rich diets and 
epithelial loss (Siar et al., 2003; Marsh, 2006).   
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2.1.3 Growth requirement and susceptibility 
2.1.3.1 Influence of oral fluids 
Saliva provides moisture and helps in lubricating the oral cavity.  It also 
promotes the formation of thin film approximately 0.1 mm deep over all external 
surfaces in the oral cavity.  Saliva is produced by the major and minor salivary glands.  
The major salivary glands consist of paired parotid, submandibular and sublingual 
glands; whereas, the minor salivary glands are found in the lower lip, tongue, palate, 
cheeks and pharynx.  The chemical composition of secretions from each gland is 
different; however, the major role of the whole saliva is to maintain the integrity of 
teeth by clearing off food debris and buffering the potential damaging acids produced 
by the oral biofilm or dental plaque.  Bicarbonate, phosphates and peptides are 
examples of buffering agent in the saliva which gives normal saliva a mean pH of 6.75 
to 7.25 (Marsh and Martin, 2009). 
 
The flow rate of saliva is under the influence of circadian rhythms where the 
lowest flow often recorded during sleeping.  Low flow rate of saliva reduces the 
protective function of saliva and increases the colonisation and development of 
microorganisms including Candida sp.  Salivary composition is also affected by 
circadian rhythms for example the total concentration of protein in whole saliva during 
resting time is estimated at 220 mg/100 mL, whereas the total protein in stimulated 
saliva is estimated at 280 mg/ 10 mL.  This different amount of protein may affect the 
distribution of the normal microflora in the oral cavity as some proteins are known to 
serve as receptors in the colonisation of microorganisms to the saliva-coated surfaces of 
the teeth (Marsh and Martin, 2009).  Protein and glycoprotein such as mucin in the 
saliva act as the primary source of nutrients for resident microflora including the 
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candidal species.  In addition to adherence, some proteins are also involved in host‟s 
defence mechanism by aggregating exogenous microorganisms, hence, facilitating their 
clearance from the mouth during swallowing or spitting. 
 
In addition to saliva, the gingival crevicular fluid (GCF) in the oral cavity can 
also influence the colonisation of oral Candida sp.  The flow of GCF is slow at healthy 
sites but increased drastically at areas with gingivitis by 147% and up to 30-fold at areas 
with advanced periodontal diseases.  GCF also has a role in the development of 
subgingival plaque around and below the gingival margin.  Among the host defence 
components in GCF are includes IgG and neutrophils.  GCF also contains higher total 
protein compared to saliva.  Thus, GCF is capable of providing nutrient sources to 
several commensal microorganisms in the oral cavity (Marsh and Martin, 2009).   
 
2.1.3.2 Influence of nutrients 
 Candida sp. is a chemoheterotrophic organism that requires carbon and nitrogen 
for growth.  According to Madigan and Martinko (2006), the mutual interaction of 
carbon and nitrogen is important in the metabolism of microorganisms. Carbohydrates 
are the most readily utilised form of carbon in both oxidative and non-oxidative way.  
Thus, the presence of carbohydrates influenced the colonisation of Candida sp. in the 
oral cavity.  Certain carbohydrates such as sucrose and glucose have been shown to 
increase the adhesion potential of Candida albicans towards hard and soft surfaces of 
oral cavity.  Glucose is an acid promoters which will lead to the reduction of pH in oral 
environment with consequence of activation of acid proteinases and phospholipases 
which then enhances the adherence of Candida sp.  In addition, the production of 
mannoprotein surface layer in the glucose presenting environment has been shown to 
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assist the adherence of Candida sp. including Candida krusei in the oral cavity (Marsh 
and Martin, 2009).   
 
 Candida sp. has nitrogen content of around 10% of their dry weight (Wai, 
2009).  The source of nitrogen is usually provided by organic compounds which can be 
easily found in the oral environment.  Nitrogen is also determined as the main 
stimulatory factor in yeast extract as it encourages bio-stimulation on microbial growth. 
 
2.1.3.3 Influence of body temperature 
The optimum growth temperature for candidal species including Candida krusei 
has been shown to range between 30 ºC to 37 ºC (Singh et al., 2002).  This range of 
temperature is considered as the optimum temperature of various pathogenic 
microorganisms in the oral cavity. Any alteration in the normal body temperature may 
however influence the competitiveness among the normal microflora which will then 
enhances the development of opportunistic microorganisms such as Candida sp.  
Nonetheless, many experimental assays were conducted at 37 ºC and this is generally 
accepted as the standard incubation temperature for candidal species (Marsh and 
Martin, 2009). 
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2.1.4 Pathogenic determinants of Candida 
The virulent factors of each different candidal species are not similar and can be 
a comparative factor between each different species (Haynes, 2001).  Among the 
important virulent factors of Candida sp. include phenotypic switching, adherence to 
host cells, cell surface hydrophobicity and enzymes production. 
 
2.1.4.1 Phenotypic switching 
Phenotypic switching is an important technique of survivorship of Candida sp. 
within a growth environment including the oral cavity.  Switching ability promotes 
Candida sp. to adapt in suppressed environment and develop as the dominant host 
microniches.  Candida sp. can undergo reversibly high frequency of phenotypic 
switching which increases and ensures the survivability of the pathogen (Haynes, 2001).  
The details of this virulence factor will be further discussed in section 2.3. 
 
2.1.4.2 Adherence ability 
The adherence ability of Candida krusei is an important factor in the initiation 
of oral candidosis.  Adherence can occur either on the hard tissue surfaces such as the 
teeth and palatal surface or smooth surfaces such as the buccal and lingual surfaces 
(Samaranayake et al., 1994).  Several characteristics of candidal species which 
contribute to the adherence on these surfaces include the formation of pseudohyphae 
and extracellular matrix.  
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A single filament hypha (plural, hyphae) is a long branching filamentous 
structure of fungus which can be found easily in the developmental phase of Candida 
sp. (Madigan and Martinko, 2006).  It is classified as the main mode of vegetative 
fungal growth and consists of one or more cells which are surrounded by tubular cell 
walls made of chitin.  Hyphae usually grow together to form a compact tufts which are 
known as mycelium.  Hyphae formation is usually referred to the germination of fungi.  
However, it is also involves in the colonisation of the target host.  Pseudohyphae are 
distinguished from the true hyphae by their method of growth which lacks cytoplasmic 
connection between the cells.  The pseudohyphae of Candida sp. are usually found to 
possess incomplete budding blastoconidia whereby cells remain attached to the mother 
cells after division.  Candida albicans and Candida krusei has been recognised to 
develop pseudohyphae which adhere to the monolayer of human epithelial cells (Soll, 
1992; Dede and Okungbowa, 2009). 
 
In many cases, extracellular matrix is also produced by oral microorganisms.  
Extracellular matrix is a network of non-living mass which provides support to cells 
including the Candida sp.  The presence of extracellular matrix provides support to cells 
attachment.  This anchorage property assists the colonisation of candidal species to hard 
tissue surfaces and thus, contributes to the formation of biofilm.  When in a biofilm, the 
resistance of candidal species towards various antifungal agents including amphotericin 
B might be increased (Hawser et al., 1998).   
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2.1.4.2.1 Dental biofilms 
Dental biofilm is defined as a thin layer comprising of various communities of 
microorganisms including bacteria, fungus and yeast that are attached on tooth surfaces 
and on the surface of prosthesis including dental acrylic surfaces and human epithelial 
cells (Holmes et al., 2002; McCarron et al., 2004).  Microorganisms in the biofilm are 
enclosed in a matrix of extracellular polymeric substance (EPS) (Branchini et al., 1994; 
Samaranayake et al., 2002).  This biofilm provides protection to the microorganisms 
and facilitates the interaction among themselves with the contribution of biochemical 
substances such as catalase and superoxidase dismutase (Socransky and Haffajee, 2002; 
Marsh, 2004; Marsh, 2006).  The development of biofilm is dependent on the dietary, 
salivary and oral environmental factors that interact with the microorganisms within the 
community of biofilm.   
 
The formation of biofilm has been shown to reduce the susceptibility of 
microorganism to antimicrobial agents which may then lead to the increase in 
pathogenicity (Marsh, 2006).  This phenomenon is suggested to occur due to the 
restriction of the antimicrobial agents to penetrate the matrix of the biofilm which then 
reduces the susceptibility of the target microorganism (Gilbert et al., 2002).  In some 
cases, the resistance of a pathogen in a biofilm can increase to 1000-fold towards an 
antibiotic (Stewart and Corteston, 2001). 
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2.1.4.2.2 Development of dental biofilms 
  The development of dental biofilm involves several stages which are the 
acquired pellicle formation on the teeth surface; adhesion, reversible and irreversible 
interactions between the pellicle and the colonising microbes; co-aggregation between 
microorganisms; and detachment of microbes from the oral surfaces.  These sequences 
of events may eventually form a structural and functional organised microbial 
community that if allowed to accumulate, may enhance the potential of periodontal 
disease and dental caries (Marsh, 2004; Wan Nordini Hasnor, 2007). 
  
The acquired pellicle formation is the formation of a thin, acellular layer which 
works as the receptor of the attachment of the early plaque colonies such as 
Streptococcus mitis, Streptococcus oralis and Streptococcus sanguinis.  There are two 
phases involved in the formation of the acquired pellicle which are the adsorption of 
discrete protein of low molecular weight to the enamel surfaces followed by the 
adsorption of protein aggregates of high molecular weight (Hannig, 1999). 
  
The adhesion, both the reversible and irreversible adsorption properties of the 
microorganism is a pioneer stage in the development of dental biofilm.   Research has 
shown that there is a reversible interaction which involves long-range physico-chemical 
forces between the microbial and acquired pellicle on the oral surfaces (Marsh and 
Martin, 1999).  The net negative charge of the bacterial cell wall will interact with the 
negative charged glycoprotein on the pellicle through a divalent cation bridge while, the 
lipophilic adhesin of the microbial cell wall will recognise the hydrophobic receptors on 
the ephitelial cell (Schonfeld, 1992).  The van der Walls and electrostatic repulsion 
forces which produce a weak area of net attraction facilitates reversible attraction 
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between the microorganisms and the oral surface area.  On the other hand, irreversible 
interactions involve short range interactions with specific physico-chemical forces 
between adhesins and the receptors on the surface area of the microbial cell surface and 
the acquired pellicle, respectively.  Streptococcus oralis and Streptococcus gordonii are 
two examples of microorganisms involved in irreversible interaction that bind to 
mucoglycoprotein of the acquired pellicle (Murray, 1992).  
 
 Subsequent to the colonisation of the early plaque bacteria to the acquired 
pellicle, co-aggregation or co-adhesion of other microorganisms will takes place.  This 
is a process of microbial adhesion involving the late colonisers on the early colonizer of 
dental biofilm.  It is a phenomenon of cell-to-cell recognition of genetically distinct 
partner cell types (Marsh and Martin, 1999).  The co-aggregation can be facilitated 
either through intrageneric such as the interaction between streptococci and among 
Actimomyces (Streptococcus sanguis and Actinomyces sp.) or intergeneric such as the 
interaction between Streptococci and Actinomyces (Streptococcus sp. or Actinomyces 
and Prevotella sp.).  Candida krusei has been found to be involved in co-aggreagation 
with Streptococcus mutans, Streptococcus sanguis and Streptococcus salivarius in the 
present of sucrose (Kiyora et al., 2000).  Protein such as lectins is usually involves in 
co-aggregation.  This carbohydrate-binding protein will attach to the carbohydrate-
binding protein receptors of other cells which then contribute to the increased thickness 
of the dental biofilm. 
  
Once a climax community is achieved in the biofilm, detachment of some 
microbes may occur in the final process oral biofilm development.  The microorganism 
is released from the matrix of biofilm to the fluid surrounding the biofilm a process 
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which have been reported to be facilitated by several enzymes such as protease (Hunt et 
al., 2004), fluid shear stress (Stoodley et al., 2001), multivalent cross-linking cation 
(Caccavo et al., 1996) and microbial growth status (Jackson et al., 2002).  This process 
of detachment will however help the microorganism to colonise other surfaces in the 
oral cavity.  An example of microorganism involved in the detachment process from the 
oral biofilm is Prevotella loescheii which produces protease that hydrolyse its fimbrae-
associated adhesion which is important in its co-aggregation with Streptococcus oralis 
(Cavedon and London, 1993; Marsh and Martin, 1999). 
 
2.1.4.3 Cell surface hydrophobicity 
The virulence factor of Candida krusei can also be observed from the cell 
surface hydrophobicity characteristic.  This factor is classified as one of the most 
important adherence mechanisms in the colonisation of the host surface.  Candida 
krusei is more hydrophobic compared to other medically important Candida sp. 
(Samaranayake et al., 1993).  Candida krusei was reported to possess the same 
hydrophobicity level with Candida glabrata and Candida tropicalis but is more 
hydrophobic compared to Candida albicans and Candida parapsilosis.   
 
2.1.4.4 Enzyme 
Hydrolytic enzymes of Candida sp. have been reported to contribute to the 
pathogenicity in causing oral diseases such as oral candidosis.  The enzymes include 
aspartyl proteinase, phospholipases, lipases, phosphomonoesterase and hexosaminidase 
(Williams et al., 2011).  Among these enzymes, aspartyl proteinase has attracted most 
interest and is widely considered to be central in the development of candidal infection.  
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Aspartyl proteinase is a hydrolytic enzyme which is secreted by the transcription and 
translation of sphingolipid activator protein (SAP) gene.  This enzyme has the ability to 
attack host and also contributes as a defence system of yeast.  Examples of candidal 
species possessing this enzyme are Candida albicans and Candida krusei 
(Samaranayake, 1994). 
 
 Another important hydrolytic enzyme is phospholipase which is identified as an 
enzyme that attacks the host tissue.  This enzyme activity has been observed in many 
fungal pathogens including Candida sp.  There are 4 types of phospholipases which are 
type A, B, C and D.  Phospholipase A and C can be found in Candida albicans; 
however, there is no evidence that shows the activity of phospholipase B and D in 
candidal species (Samaranayake, 1994).  Phospholipase A can attack cell membranes 
and can be easily found on the cell surface especially at the sites of bud formation.   
Hence, the enzyme activity can be enhanced when the hyphae are in direct contact with 
the host tissue (Williams et al., 2011).   
 
2.2 Candida krusei 
 Candida krusei is classified as a facultative saprophytic fungus that is 
infrequently isolated from the human mucosal surface area (Do Carmo-Sousa, 1969; 
Odds, 1988; Thein et al., 2007).  This pathogenic yeast has been detected as an oral 
commensal and represented between 10% to 15% of yeasts isolated from the oral cavity 
of human.  Since the 1960s, Candida krusei has emerged as a pathogen associated with 
the development of oral candidosis (Samaranayake, 1994). 
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2.2.1 Taxonomic status 
Candida sp. is classified under the family of Cryptococcaceae as imperfect 
fungi.  The family of Cryptococcaceae includes the genera Torupsilosis and 
Cryptococcus.  The strain is recognised as the causative agent of thrush which infects 
the mucosal layer including tongue, lips, gums or palate.  The association of this 
numerous generic and variable species of microorganisms and the lesion formed in the 
oral cavity is called “thrush fungus” (Odds, 1988).   
 
Candida krusei has been discovered since 1839 by Langenbeck and was firstly 
isolated from the buccal epithelial layer in a typhus patient.  However, it was 
unclassified as pathogenic to human until 75 years later when Castellani found that the 
strain was actually a commensal in warm-blooded animals (Castellani, 1912; 
Samaranayake and Samaranayake, 1994).  In general, the yeast morphology of Candida 
krusei comprises of asexual and sexual species.  The sexual form was renamed as 
Issatchenkia orientalis whereas the asexual form had remained as Candida krusei (Odds 
and Merson-Davies, 1989). 
 
2.2.2 Biology of Candida krusei 
Candida krusei is classified as yeast that possesses elongated cell shape with 
“long grain rice” appearance.  The appearance of this cell is shared with Candida kefyr 
or also known as Candida pseudotropicalis (Samaranayake, 1997).  The measurement 
of Candida krusei is approximately 2.2 to 5.6 x 4.3 to 15.2 µm.  It forms spreading 
colony with matt or rough whitish yellow surface on SDA which in a way enable us to 
identify it directly from morphological observation (Samaranayake and Mac Farlane, 
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1990).  The ultra structure of Candida krusei comprised of a six-layered cell wall with a 
few intra-cytoplasmic organelles including small vesicles, lipid droplets, ribosomes and 
glycogen-like particles (Joshi et al., 1975).  The multilayered cell wall of Candida 
krusei comprise of an outer irregular coat of flocculent material, an electron dense zone, 
a granular layer, less granular layer, a thin layer of dense granules and another sparsely 
granular layer outside the trilaminar cell membrane (Samaranayake and Samaranayake, 
1994).   
 
Candida sp. may exist in three morphological forms which are blastospores 
(yeast-like ovoid cells), filamentous hyphae and chlamydiospores (dormant phase of the 
microorganism).  Chlamydiospores is a thick-walled spherical cell with approximately 
10 µm in diameter (Melville and Russells, 1975).  In many causes however, Candida 
krusei is usually found in only two basic morphological forms which are the yeast and 
pseudohyphae forms.  Pseudohyphae are important in the adherence of cells to the 
surfaces of the host (Soll, 1992; Dede and Okungbowa, 2009).  Both characteristics may 
however appear simultaneously thus making it difficult to differentiate between these 
two basic characteristics.   
 
Candida krusei can grow in an environment with temperature ranging from 35 
ºC to 45 ºC (Odds, 1988).  A characteristic that gives advantage to Candida krusei is 
that it can grow in vitamin-free media, which is a major contrasting feature from the 
other clinically important Candida sp.  It is also reported that from a wide panel of 
carbohydrates component Candida krusei can only ferment glucose (Barnett et al., 1983 
and Silverman et al., 1990) which is also displayed by Candida pintolopesii.  It has 
been shown that when saliva is supplemented with glucose, a number of short-chain 
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carboxylic acids such as acetate, pyruvate, succinate, propionate, lactate and formate 
will be formed.  Another feature that adds to the advantage of Candida krusei is that it 
can produce acetoin which can be utilised when the growth environment is exhausted of 
carbon sources (Lategan et al., 1981).   
 
2.3 Phenotypic switching ability of oral Candida 
Two mechanisms were postulated to be involved in the ability of Candida krusei 
to survive and adapt in a suppressed environment.  First is by undergoing mitotic 
recombination and second is by carrying out phenotypic switching.  A direct 
consequence of mitotic recombination is the lost of heterozygosity throughout the entire 
genome.  This deletion of genome however affects the viability of Candida sp. 
especially in the multiple changing conditions (Vargas et al., 2004).  Phenotypic 
switching, on the other hand is a phenomenon that occurs as a result of changes in the 
growth environment.  A severely suppressed growth condition may lead to high 
frequency switching in candidal cells.  This adaptation is associated with the alteration 
of gene expression which eventually may lead to alteration of adhesiveness, 
susceptibility and the resistance of candidal cells to phagocytosis and 
polymorphonucleur leukocyte.  This mechanism of action does not involves deletion of 
any candidal genome thus, the heterozygosity of the entire genomic are well maintained 
(Martin and Marsh, 2009).   
 
Phenotypic switching is identified as one of the important virulent factors in 
Candida albicans (Anderson et al., 1987; Soll, 1992; Jones, et al., 1994; Vargas, et al., 
2004) and Candida glabrata (Lackhe et al., 2000; Lackhe et al., 2002).  The 
significance of the switching strategy is in a way similar to the human immunity 
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function whereby it is aimed to counter threats in the host‟s environment.  Until now, 
there is no report that highlights the ability of Candida krusei to undergo phenotypic 
switching.  However, scientist has suggested that phenotypic switching mechanism 
enhances the survivability of Candida sp. by rapidly changing its phenotype as an 
adaptive response to the suppressed environment (Hellstein et al., 1993).   
 
Phenotypic switching may influence the normal physiological growth of 
candidal species such as Candida albicans (Vargas et al, 2004).  Under the smooth 
white and wrinkled phenotypes, Candida albicans has been shown to exhibit faster 
growing colonies than when it exhibited a heavy myceliated and ring phenotype.  In 
addition, phenotypic switching is also discovered to be able to alter the adhesiveness 
properties of Candida sp. (Kennedy et al., 1988).  Furthermore, this virulence attribute 
may also induce the formation of tube and pseudohyphae in Candida sp. which then 
enhance the adherence capacity of the candidal strains (Lackhe et al., 2002).    
 
2.4 Management of candidal infection 
2.4.1 Antimicrobial agents 
Antimicrobial agents are described as drugs which selectively help to eliminate 
microbial pathogens from host cell due to toxicity mechanism.  There are three 
categories of antifungal agents available for the treatment of candidosis.  They are 
polyenes, azoles and the DNA analogue 5-fluorocytosine.  Examples of polyenes are 
nystatin and amphotericin B, while the azoles include miconazole, fluconazole, 
clotriminazole, ketoconazole and itraconazole.  The principal of antifungal agents used 
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against yeast infections in the oral cavity belongs to the first two categories which are 
the polyenes and the azoles (Samaranayake & Ferguson, 1994). 
 
2.4.1.1 Disinfectant 
2.4.1.1.1 Chlorhexidine 
Chlorhexidine (CHX) has antifungal and antibacterial properties.  The principle 
of treatment with CHX is based on the rapid absorption of the chemical component into 
the surface of the microorganisms which increases the permeability of the cell 
membrane.  As a result, it causes precipitation of the cytoplasmic content which then 
kills the microorganism directly (Davies, 1973).  It is also widely used in the treatment 
of oral candidosis (Budtz-Jorgansen and Loe, 1972; Kulak et al., 1994).  Regular 
rinsing with chlorhexidine helps in the treatment of this disease (Langslet et al. 1974).  
However, the prolonged usage of CHX may stain the dental hard tissue surfaces 
brownish. 
 
2.4.1.2 Chemical-Based agents 
2.4.1.2.1 Azoles 
These antifungal agents have five-member of organic rings containing two or 
three nitrogen molecules (Anil, 2002).  Azoles are categorised as N-1 substituted 
imidazoles and triazoles.  Imidazoles that are usually used clinically includes 
ketoconazole and miconazole while the triazoles include the itraconazole and 
fluconazole.  Triazoles such as fluconazole are inhibitor of cytochrome p-450 enzyme 
which is involved in the general synthesis of fungal cell membrane.  The principal 
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action of azoles is through the conversion of 14-α-methylsterol to ergosterol within the 
fungal membrane as such conversion may lead to the blockage of 14-α-demethylation 
step in the synthesis of ergosterol.  As a result, the composition of ergosterol will 
deplete whereas the 14-α-methysterol will accumulate and becomes permeable to the 
intracellular constituents.  This target process is known as 14-α-demethylase.  
Imidazoles on the other hand may interfere with the fungal oxidative enzymes which 
then lead to lethal accumulation of hydrogen peroxide in the cell (Anil, 2002). 
 
2.4.1.2.1a Fluconazole 
Fluconazole is an antifungal agent which is commonly used in the treatment of 
candidal infection such as oral candidosis.  It is a water-soluble chemical compound 
which can be found in the form of tablet, oral solution and saline-based intravenous 
solutions (Anil, 2002).  In a bulk powder form, it appears as a white crystalline powder 
with slight solubility water and alcohol.  The absorption of fluconazole has been 
reported to be unaffected by food or gastric acidity (Lim et al., 1991; Debruyne and 
Ryckelynck, 1993; Zimmermann et al., 1994). 
 
Fluconazole has been useful in the prevention of Candida albicans-associated 
endocarditis and diseases caused by Candida parapsilosis and Candida tropicalis.  
However, this antifungal agent was found to be ineffective towards Candida krusei and 
Candida glabrata (Van‟t Wout, 1996; Samaranayake, 1997; Venkateswarlu et al., 1997; 
Singh et al., 2002).  In other species, fluconazole exerts fungistatic affects.  This 
fungistatic azoles is often used for lifetime therapy of AIDS patients.  This is of concern 
as long-term usage may lead to drug resistance especially when switched candidal 
species are involved (Baily et al., 1994).  
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2.4.1.2.1b Voriconazole 
 Voriconazole is a triazole derivative of azoles with a wide range of effectiveness 
in the treatment of fungi including Candida sp., Aspergillus sp. and Cryptococcus 
neoformans.  In comparison to fluconazole therapy, voriconazole exhibited 1.6 to 160-
fold greater inhibition of ergosterol P-450-dependent α-demethylase in Candida 
albicans, Candida krusei and Aspergillus fumigates (Sheehan et al., 1999).  
Voriconazole is more potent in inhibiting the growth of Candida krusei compared to 
fluconazole with 16-fold higher than the treatment on Candida albicans (Fukuoka et al., 
2003).   
 
2.4.1.2.2 Polyenes 
 The polyenes are antifungal drugs that target the cell membrane containing 
ergosterol.  Polyenes include nystatin and amphotericin B which are categorised as the 
amphipathic; having both hydrophobic and hydrophilic sides.  It acts as an agent that is 
able to intercalate into membrane layer and forming channels causing potassium ions to 
leak out of the cell and destroy the proton gradient of Candida sp. (Vanden Bossche et 
al., 1994). 
 
2.4.1.2.2a Amphotericin B 
 Amphotericin B is a polyene which posses both fungicidal and fungistatic 
activities that are broad-spectrum against Blastomyces dermatidis, Coccidioides imnitis, 
Crytococcus neuformans, Histoplasma capsulatum, Paracoccidioides brasiliensis, 
Sporotrichium sp., Candida glabrata and Candida albicans except Candida lusitaniae 
which is resistant.  This topical antifungal agent is usually used in treating primary oral 
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candidosis and used as an adjunct to parenteral therapy in secondary candidosis with 
manifestations of both systemic as well as on oral mucosal surfaces (Samaranayake et 
al., 2009).   
 
Amphotericin B acts on the sterol on the cell walls of the target cells which then 
damages the cell walls and releases the ionic content including potassium and glucose.  
This phenomenon leads to the inhibition of glycolysis which then inhibits the growth of 
the candidal species (Anil, 2002).    
 
2.4.1.2.2b Nystatin 
 Nystatin was discovered in 1949, obtained from Streptomyces noursei that was 
found in the soil sample of a farm in Virginia.  It is found to be the most established 
antifungal agent that is effective in the treatment of superficial fungal infection caused 
by Candida sp.    Nystatin can damage the cell membranes of yeasts by altering the 
permeability (Kerridge, 1986).   The reaction starts when nystatin binds to the sterol 
component in the membrane of the yeast and alters the permeability.  Nystatin has the 
ability to treat superficial fungal infection caused by Candida sp.  It has been shown to 
exhibit both the fungistatic and fungicidal activities.  However, nystatin is a poor 
therapy for oral candidal infection.  It is poorly absorbed by the host and usually it is 
passed unchanged through the gastrointestinal tract (Anil, 2002). 
 
 Furthermore, it is discovered that nystatin can suppress the adhesion of Candida 
albicans to cells of the buccal epithelium (Macura, 1987; Vuddhakul et al., 1988; Abu-
el Teen et al., 1989).  Nystatin can also inhibit the formation of germ tube which is 
25 
 
known as the virulence factor of selected candidal strains such as Candida albicans and 
Candida dubliniensis. 
 
2.4.1.3 Plant-based agents 
2.4.1.3.1 Family Piperaceae 
 Piper betle is a plant belonging to the Piperaceae which originated from the 
South East Asia including India, Sri Lanka and Bangladesh.  The betel leaf itself is 
known as Sireh (Malay), Paan (Urdu and Hindi), Vetrilai (Tamil) and Ikmo 
(Philippines).  Piper betle plant is an evergreen plant with glossy heart-shaped leaves 
with white catkin.  Usually, the leave is chewed together with betle nut, lime and 
gambier leaves.  The nut gives the reddish colour to the saliva and thus darkens the 
teeth.  Betle leave is believed to be a folk medicine in the treatment of various diseases 
including bad breath, headache, boils, conjunctivitis, itches, mastitis, mastoiditis and 
ringworm (Chopra et al., 1956).  The essential oil of Piper betle was reported to contain 
antibacterial, antiprotozoan and antifungal properties.  Research has shown that the 
plant may produce bacteriostatic and fungistatic effects against Salmonella thyphi, 
Escherichia coli and Candida albicans respectively (Indu and Ng, 2002; Guha, 2006).   
 
Piper betle was found to be effective as anti-dermatophyte against Candida 
albicans, Microsporum gypseeum and Trichosporon beigelii and phyto-pathogen such 
as Sclerotium rolfsii, Alternaria solani and Phytophthora infestons (Rahman et al., 
2005).  The extract of this plant was also identified as an important antioxidant which 
scavenged the free radicals and detoxify the organism which then prevented 
cardiovascular disease, cancers (Gerber et al., 2002; Serafini et al., 2002), Parkinson‟s 
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and Alzheimer‟s diseases (Di Matteo and Esposito, 2003).   The leaf extract was 
identified to inhibit radiation-induced lipid peroxidation.  In addition, the extract also 
increased the activity of superoxide dismutase which indicated the elevation of 
antioxidant status in Swiss albino mice (Chourhury & Kale, 2002).  Research has also 
proved that the antioxidant component within Piper betle leaf was higher than tea 
(Dasgupta and De, 2004).  The active compounds which were identified from the 
extract include chavicol, chavibetol, allylpyrochatichol, chavibetol acetate and 
allylpyrochatichol diacetate.  Various nutritional compounds has been identified to be 
present in Piper betle extract which include vitamin A, vitamin B, iodine, iron, calcium, 
potassium, tannin, riboflavin and carbohydrate.  Furthermore, the leaf was also said to 
contain enzymes such as diastase and catalase (Guha and Jain, 1997).   
 
Piper betle crude aqueous extract has been reported to reduce the cell surface 
hydrophobicity of Streptococcus sanguis, Streptococcus mitis and Actinomycetes sp. 
(Fathilah et al., 2006).  Hydrophobicity is an important mechanism which enhances the 
adherence of pathogen to saliva-coated teeth surface.   
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Figure 2.1:  The leaves of Piper betle. 
 
Figure 2.2: Piper betle tree. 
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2.4.1.3.2 Family Ranunculaceae 
Nigella sativa is a herbaceous plant which is known as fennel flower plants 
derived from Ranunculaceae or Buttercup family.  The maximum height of this plant is 
about 60 cm with blue flower producing small-caraway black seeds (Khan, 1999; Al-
Jabre et al., 2003).  The plant is also known as black cumin (English), shonaiz (Persian), 
krishnajirika (Sanskrit), kalajira (Bangali), kalonji (Urdu and Hindi) and Habbatus-
sawda (Arabic).  It is a common plant in the Middle East, Eastern Europe, Western and 
Middle Asia.  This plant has been identified as a remedy for many ailments since the 
ancient times of the Egyptian, Romans and Greeks (Al-Jabre et al., 2003).  The 
medicinal parts of Nigella sativa were reported in the book  of medicine Canon fi Tibb 
by Avicenna which states that the black seed is a good medicine which acts as 
expectorant, stimulates body‟s energy and helps in the recovery from fatigue and 
dispiritedness.  In the Quran, the black seed is known as the cure for any kind of known 
disease except death (Al-Bukhari, verse 815).  Besides medicine, it is also used as a 
flavour for bread and pickles.  Many active ingredients are found from Nigella sativa 
which include thymoquinone, thymol, dithmoquinone, thymohydroquinone, carvacrol, 
nigellicine, nigellidine, nigellimine-N-oxide and alpha-hedrin (Canonica et al., 1963; 
Mahfouz and El-Dakhakhny, 1966; El-Alfy et al., 1975; Khan, 1999, Randhawa and 
Al-Ghamdi, 2002; Al-Jabre et al., 2003).   
 
Thymoquinone and thymohydroquinone present in the extract of Nigella sativa 
were reported to have anti-inflammatory activities.  Studies on rat perionatal mast cells 
have shown that nigellone at low concentrations worked as an active inhibitor of 
histamine which is produced during cell-antigen segregation.  The action was created 
due to the inhibition of protein kinase-C and the decrease of calcium concentration 
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which is involved in an inflammation mechanism.  These results have suggested that the 
nigellone can be used as an effective medicine in the prevention of asthma and allergic 
condition (Zawahry, 1963; Chakravarty, 1993; Khan, 1999).    Thymoquinone which is 
the active component of Nigella sativa acted as anti-fungal agent towards Candida 
albicans (Al-Jabre et al., 2003), Tricophyton rubrum (Al-Jabre et al., 2005) and 
Aspergillus sp. (Al-Qurashi et al., 2007).   Thymohydroquinone is also able to inhibit 
the growth of Gram positive microorganism such as Escherichia coli.  Diethyl-ether 
extract of Nigella sativa was found to be effective on Staphylococcus aureus, 
Pseudomonas aeruginosa and Escherichia coli.  It was also discovered to act 
synergistically with streptomycin and gentamycin (Atta-ur-Rehman et al., 1985; Morsi, 
2000). 
 
In the early 1960‟s, researchers found that the volatile oil of Nigella sativa 
contained antimicrobial component (Toppozoda et al., 1965).  The oil was found to 
inhibit the growth of certain Gram positive bacteria such as Streptococcus aureus, Gram 
negative bacteria such as Escherichia coli and fungi such as Candida albicans.  
Furthermore, the fractionation process of the oil which produces the phenolic content 
was found to increase the effectiveness of the oil up to ten thousand times and is non-
toxic to human (Toppozoda et al., 1965). 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3:  The seeds of Nigella sativa. 
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3.0 MATERIALS AND METHODS 
3.1 RESEARCH MATERIALS 
3.1.1 Chemicals 
Decon 90 (Decon, England) 
Dibasic sodium phosphate anhydrous powder (Sigma, USA) 
Ethanol 95% (John Kollin Corporation, USA) 
Germisep (Hovid, Malaysia) 
Glutaraldehyde 
Glycerol (Merck, Germany) 
Monobasic potassium phosphate (Sigma, USA) 
Osmium tetraoxide 1% 
Phloxine B (Sigma, USA) 
Potassium chloride (Sigma, USA) 
Savlon (Johnson and Johnson, Malaysia) 
Sodium chloride (BDH, England) 
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3.1.2 Glasswares 
Beaker (Bibby, UK) 
Conical flask (Pyrex, England) 
Glass beads (3 mm diameter) (Merck, Germany) 
Glass bottle (Schott, UK) 
 
3.1.3 Consumables 
Aluminium foil (Diamond, USA) 
Blank disk (Oxoid, UK) 
Bunsen burner gas (Campingaz, France) 
Microtitre plate (96 wells) (Nunc, Denmark) 
Petri dish (Brandon, USA) 
Pipette tips (Appendorf, Canada) 
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3.1.4  Media 
Bacto agar powder (BD, USA) 
D (+) Glucose (Sigma, USA) 
Mueller-Hinton (MH) agar powder (BD, USA) 
Peptone powder (BD, USA) 
Yeast extract powder (BD, USA) 
 
3.1.5  Antifungal agents 
Amphotericin B (250 µg/mL) solution (PAA, Germany)  
Chlorhexidine digluconate (20%) (Sigma, USA) 
Fluconazole (25 µg) discs (Oxoid, UK) 
Nystatin (100 µg) discs (Oxoid, UK) 
Voriconazole (1 µg) discs (Oxoid, UK) 
 
3.1.6 Plant specimens 
Nigella sativa (Durra, Syria) 
Piper betle (Kedah, Malaysia) 
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3.1.7 Microbial test strain 
Candida krusei (ATCC 14243), American Type Culture Collection, USA. 
 
3.1.8 Microbial identification system 
API 20 C AUX (BioMériux, France) 
BIOLOG YT Micro Plates (BIOLOG, USA) 
Mc Farland standards (BD, USA) 
 
3.1.9 Equipments 
Analytical balance, Denver XL-1810 (USA) 
Analytical balance, Mettler AJ100J and Denver XL-1810 (USA) 
Autoclave, HICLA VE HVE-50 (Hirayama, Japan) 
Chiller, 4 ºC (Mutiara, Malaysia) 
Compact digital camera (Olympus, Japan) 
Digital Camera Light Reflection (DSLR) D90 (Nikon, Japan) 
Electric drying cabinet, Weifo KD-112 (Weifo, Singapore) 
Freezer, -80 ºC, Hetofrig CL410 (Hetofrig, Denmark) 
Fume cupboard, Ductless Labcaire 4850 (Labcaire, England) 
Haemacytometer (Marienfield, Germany) 
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Hotplate (Cimarec 3, USA) 
Incubator (Memmert, Germany) 
Laminar flow unit, ERLA CFM Series (Australia) 
Light microscope (Nikon, Japan) 
Micropipettors (Appendorf, Canada) 
Microwave oven (Panasonic, UK) 
Peristaltic pump (Bio-Rad Econo. Pump) 
Scanning Electron Microscope (JOEL, Japan) 
Spectrophotometer, Shimadzu UV160A (Shimadzu, Japan) 
Speed vacuum concentrator, HETO/HS-1-110 (Denmark) 
Sputter coater S150B (Edwards, USA) 
Stereoscope (Olympus, Japan) 
Thermocirculator E3500 (Polaron, UK) 
Vortex mixer (Glas-Col, USA) 
Water distiller (J Bibby Merit) 
Water purifier system (ELGA, UK) 
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3.2 RESEARCH METHODS 
3.2.1 Research outline 
 
 
 
 
 
 
 
 
 
“ 
 
 
 
 
 
Figure 3.1: Schematic diagram of research methodology. 
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3.2.2 Preparation of broth media 
3.2.2.1 Yeast extract potato dextrose (YEPD) broth  
Table 3.1: Compounds required for making YEPD broth. 
Materials g 
D (+) Glucose 20 
Peptone powder 20 
Yeast extract powder 10 
 
All the nutrients above were dissolved in 1 L of distilled water and boiled in a 
microwave oven.  The mixture was sterilized by autoclaving at 121 ºC for 15 minutes at 
15 psi. The sterilized YEPD broth was kept in the 4 ºC refrigerator for later used within 
a time period of a month. 
 
3.2.2.2 YEPD broth supplemented with phloxine B 
 1 L of YEPD broth was prepared as above and 0.005 g of phloxine B (0.05%) 
was added to the broth mixture. Phloxine B was mix thoroughly.  The supplemented 
broth was then sterilized by autoclaving at 121 ºC for 15 minutes at 15 psi and kept at 4 
ºC for further use in the experiment.  The prepared media was best to be used within a 
month. 
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3.2.3 Preparation of agar media 
3.2.3.1 Yeast extract potato dextrose (YEPD) agar  
Table 3.2: Compounds required for making YEPD agar. 
Materials g 
D (+) Glucose 20 
Peptone powder 20 
Yeast extract powder 10 
Bacto agar powder 20 
 
All nutrients above were dissolved in 1 L of distilled water and boiled in a 
microwave oven.  The mixture was autoclaved at 121 ºC for 15 minutes at 15 psi.  The 
sterilized media was poured into sterile petri dishes and left to solidified.  
 
Agar slants were also prepared by dispensing approximately 3 mL of the 
sterilized agar into the sterile universal bottles and left to solidify on a slant bench 
surface.  The solidified YEPD agar plates and slants were stored 4 ºC refrigerator for 
later use within a period of a month.  The agar plates were stored in an inverse direction 
until the next usage and were best used within a period of a month. 
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3.2.3.2 YEPD agar supplemented with phloxine B 
1 L of YEPD agar suspension was prepared as above and 0.005 g of phloxine B 
(0.05%) was added to the agar mixture and boiled in a microwave oven.  Similar 
sterilization procedure to section 3.2.2.1 was carried out.  The sterilized media was then 
poured into sterile petri dishes and left to solidified.  
 
Agar slants were also prepared by dispensing approximately 3 mL of the 
sterilized agar into the sterile universal bottles and left to solidify on a slant bench 
surface.  The solidified YEPD agar plates and slants were kept in the 4 ºC refrigerator 
for later use within a month.  The agar plates were kept in inverse direction until the 
next usage.  
 
3.2.3.3 Mueller-Hinton (MH) agar  
38 g of MH agar powder were dissolved in 1 L of distilled water and boiled in a 
microwave oven.  The mixture was then sterilized following the procedure in section 
3.2.2.1.  The sterilized medium was then poured in sterile petri dishes and left to 
solidified.  All plates were kept at 4 ºC in an inverse direction and were best used within 
a period of one month. 
 
3.2.3.4 CHROMagar 
47.7 g of CHROMagar powder were dissolved in 1 L of distilled water and 
boiled in a microwave oven for 5 minutes.  The mixture was then sterilized according to 
the procedure in section 3.2.2.1 and poured in sterile petri dishes and left at room 
40 
 
temperature to solidify.  All plates were kept at 4 ºC in an inverse direction.  The plates 
were best used within a period of one month. 
 
3.2.4 Preparation of Candida krusei (ATCC 14243) stock culture 
With reference to the manufacturers‟ instruction, an ampoule containing 
lyophilised cells of Candida krusei (ATCC 14243) was added with 0.5 mL of sterile 
distilled water to rehydrate the dry pellet.  Following rehydration, 100 µL of the 
suspension was then inoculated on to YEPD agar plate and incubated at 37 ºC for 24 
hours (Lackhe et al., 2002). 
 
3.2.4.1 Short term storage on agar slants 
Several colonies of Candida krusei from YEPD agar plate were picked, 
subcultured on YEPD slants and incubated overnight and stored at 37 ºC.  It was then 
stored at 4 ºC prior to use in the experiment. 
 
3.2.4.2 Long term storage in 20% glycerol 
Glycerol stock media is required to maintain cells‟ viability for long term 
storage.  Candida krusei strain from YEPD slant was inoculated into 5 mL of YEPD 
broth and incubated overnight at 37 ºC.  Following incubation, 800 µL of the growth 
suspension was transferred into sterile microfuge tube which has been added with 200 
µL of glycerol.  The glycerol stock of Candida krusei was then stored at -80 ºC for long 
storage purposes. 
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3.2.5 Preparation of Candida krusei switched cultures  
Cells from the slant culture of unswitched Candida krusei was revived in YEPD 
broth that has been supplemented with 5 mg mL
-1
 of phloxine B dye.  This dye was 
used to create a stress growth environment for the cells (Lackhe et al., 2002).  The 
suspension was then incubated for 4 to 5 hrs at 37 ºC.  Following incubation, the 
turbidity of the growth suspension was spectrophotometrically measured and 
standardised to an optical absorbance 0.144 at a wavelength of 550 nm (10
6
 cells mL
-1
).  
The suspension was then serially diluted to give a plate count of approximately 50 cells 
each.  The suspension was then spread evenly on the agar surface and incubated 
overnight at 37 °C.  The colony forming units (CFU/mL) were then examined.  
Colonies exhibiting different characteristics from the normal were enumerated and 
photographed.  These colonies were considered as having a phenotypic switched from 
the unswitched Candida krusei and designated as the 1
st
 switched generation.  Several 
cells from the 1
st
 switched generation were again subcultured on to another set of YEPD 
(supplemented with phloxine B) agar plate and the whole procedure was repeated to 
produce the 2
nd
, 3
rd
 and 4
th
 generation of the switched cells.  The CFU/mL of each 
generation of unswitched and switched Candida krusei was calculated according to the 
formula: 
Total CFU/mL =                           Number of formed colonies 
                                                     Dilution factors x volume used (mL) 
The result was interpreted as the mean of CFU/mL and standard deviation (SD). 
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3.2.6 Determination of biological characteristics of Candida krusei 
3.2.6.1 Colony morphology  
3.2.6.1.1 YEPD agar  
Candida krusei from the slant was inoculated into 0.5 mL of YEPD broth and 
standardized to an OD of 0.144 at 550 nm.  100 µL of the suspension was then 
inoculated on to YEPD agar plate and incubated at 37 ºC for 24 hours (Lackhe et al., 
2002).  The morphology of Candida krusei which include the surface appearance, 
margin, forms and elevation were observed and recorded. 
 
3.2.6.1.2  CHROMagar 
 Using a sterile wire loop, Candida krusei was inoculated on CHROMagar using 
single colony dilution streaking method.  The plate was incubated at 37 ºC for 24 to 72 
hours.  Following incubation, the colour of the grown colonies were observed and 
recorded. 
 
3.2.6.2  Biochemical analysis 
3.2.6.2.1  API 20 C AUX identification system 
5 mL of distilled water was dispensed into each honey-combed wells of API 20 
C AUX tray to provide a humid environment.  The tray was labeled according to the 
sample used. A suspension of Candida krusei was prepared and standardized at a 
turbidity of 2 McFarland using sterile saline.  100 µL of the suspension was inoculated 
onto YEPD agar and incubated at 37 ºC for 24 hours.  Another 100 µL of Candida 
krusei suspension was inoculated into C-medium which was supplied by the 
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manufacturer in the identification system kit.  The suspension mixture was 
homogenized gently to prevent the formation of bubbles.  The homogenized suspension 
was pipetted into each of 20 cupules on the test strip placed in the tray.  The tray was 
put in an incubator at 37 ºC for 48 to 72 hours.  After incubation, the strip was 
examined and the turbidity of each cupule was compared to the control sample.  The 
positive or negative outcomes of all cupules in the strip were compared to the table 
provided by the manufacturer to confirm the species. 
 
3.2.6.2.2  BIOLOG YT MicroPlates 
The methodology was carried out according to the instruction provided by the 
manufacturer.  BIOLOG is an identification system which dependent on the substrate-
enzyme interactions of the microbial strain.  An overnight cultured of Candida krusei 
was suspended in sterile distilled water.  Later, 100 µL of the cell suspension 
standardized at 47% transmittance was inoculated into each well of the YT MicroPlates.  
The YT MicroPlates were incubated at 26 ºC for 24, 48 and/or 72 hours.  The metabolic 
patterns were interpreted by Biolog‟s MicroLog 3 computer software which matched to 
the library of species database. 
 
3.2.6.3  Cell morphology 
 Candida krusei was inoculated in YEPD broth and incubated at 37 ºC for three 
hours.  Following this, one to two loopfuls of the suspension was placed on clean glass 
slide.  With circular movement of the loop, the suspension was spread evenly into a thin 
area with approximately the size of 1 cm
2
.  The smear was fixed by air-drying.  The 
smear was then gently flooded with crystal violet and left to stand for one minute, after 
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which the stained was washed with tap water.  Later, the smear was flooded with iodine 
and left for one minute and washed with tap water.  95% of ethyl alcohol was dropped 
on the smear followed by immediate washing with tap water.  A counterstain, safranin 
was applied and left to stand for 45 seconds.  Finally, the smear was then washed with 
tap water and blot dried with tissue paper.  The slide was then examined using a light 
microscope at 100 x magnification under oil immersion. 
 
3.2.6.4  Ultrastructural characteristic  
A colony of C. krusei growing on YEPD agar was removed using a cork borer 
and transferred into a sterile petri dish.  The specimen was then fixed by immersing it in 
glutaraldehyde and Sorensen‟s phosphate solution (1:1).  After an hour, the specimen 
was washed with Sorensen‟s phosphate and distilled water (1:1) and then post-fixed 
with 1% osmium tetraoxide and distilled water (1:1) over a period of 14 hours at 4 ºC.  
The specimen was then put aside for an additional one hour at 25 ºC under a laminar 
flow.  Following that, the 1% osmium tetraoxide was gently pipetted out and the 
specimen was again washed with distilled water and put through a series of ascending 
ethanol concentrations (10%-100%) to dehydrate the specimen.  The specimen was then 
immersed in 100% ethanol twice to ensure maximum elimination of water in the 
samples.  Gradual displacement of ethanol with acetone was then carried out (20 
minutes each) using the following ratios of ethanol (EtOH) to acetone (v/v) with 3:1, 
1:1 and 1:3. 
 
Following that, the specimen was immersed in 100% acetone for four times, 20 
minutes each time, followed by critical point drying (CPD) process using the Polaron 
E3500.  The specimen was then mounted on aluminium stubs and coated with gold 
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palladium using an Edward‟s sputter coater (S150B).  The specimen was then examined 
under the scanning electron microscope (SEM) (JEOL SEM) at 2000 x magnification.  
Samples of the 1
st
, 2
nd
, 3
rd
 and 4
th
 switched cells were also similarly prepared for SEM 
examination. 
 
3.2.6.5 Growth curves 
In a sterilized Schott bottle, 50 mL of YEPD broth and 0.5 mL of Candida 
krusei was added and the concentration of the suspension was standardized to 0.144 
OD550nm (10
6
 cells mL
-1
).   The suspension was then vortexed for 30 second and the 
initial OD at 550 nm was recorded.  The bottle was placed in a shaking water bath at 37 
ºC and the growth of the cells was monitored by recording the OD reading at every one 
hour interval.  The OD reading was converted to CFU/mL and a graph of log10CFU/mL 
versus incubation time was plotted.  The experiment was stopped once the stationary 
phase was achieved.  The protocol was carried out in triplicate and repeated several 
times to ensure reproducibility (Fathilah, 2004).  The procedures were repeated and the 
growth curves of the 1
st
, 2
nd
, 3
rd
 and 4
th
 switched cell generations were also determined. 
 
3.2.7 Determination of biological characteristics of switched Candida krusei 
 The determination of the biological characteristics of switched Candida krusei 
was carried out following procedures in section 3.2.6.1 to 3.2.6.5.  Observations with 
regards to the colony and cell characteristics, the ultrastuctural changes and the growth 
curves of the switched cells were recorded.  
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The recovery population of the 1
st
 switched generation of Candida krusei was 
determined from the percentage of the total CFU/mL of switched colony of the 1
st
 
switched generation to the total CFU/mL of the unswitched Candida krusei.    Whereby, 
the recovery populations of the 2
nd
 to the 4
th
 switched generations of Candida krusei 
were obtained from the percentage of the total CFU/mL of switched colony of Candida 
krusei to the total CFU/mL of the previous switched generation of Candida krusei. 
 
3.2.8 The effect of phenotypic switching on adherence to saliva-coated hard 
surface 
3.2.8.1 Preparation of phosphate-buffered saline (PBS) solution 
Table 3.3: Chemical ingredients required for the preparation of Phosphate-Buffered 
Saline (PBS). 
Materials g 
Sodium chloride 4 
Potassium chloride 0.1 
Dibasic sodium phosphate anhydrous powder 0.72 
Monobasic potassium phosphate 0.12 
 
The chemicals were dissolved in 1 L of distilled water and standardized at pH 7.  
The solution was then autoclaved at 121 ºC for 15 minutes at 15 psi.  The pH were 
adjusted to pH 7.0 and then stored at 4 ºC.  
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3.2.8.2 Collection of stimulated whole saliva (SWS) 
SWS was collected following method described by Holmes et al. (2002) with 
some modification by Rahim et al. (2008).  25 mL of saliva was collected everyday 
from a single volunteer with healthy oral condition in order to reduce any variation 
between different individuals.  Initially, the subject was required to rinse with distilled 
water for 10 seconds to ensure the cleanliness of the oral cavity.  The volunteer was 
given a piece of rubber band to chew in order to stimulate salivary flow and SWS was 
collected in a sterile ice-chilled test tube with the addition of 1,4-dithio-D,L-threitol 
(DTT) to a concentration of 2.5 mM.  The specimen was stirred slowly before 
centrifugation at 17,000 g for 30 minutes.  The supernatant obtained was filtered 
through 0.2 µm pore low-protein binding filter (Supor® membrane) into a sterile test 
tube.  SWS was then stored at -20 ºC for use in the adherence study. 
 
3.2.8.3  Adherence to saliva-coated hard surface 
An artificial mouth model named the Nordini‟s Artificial Mouth (NAM) model 
was used in this experiment (Wan Nordini Hasnor, 2007; Rahim et al., 2008).  Saliva-
coated glass beads of 3 mm diameter were used to mimic the hard tissue surfaces of the 
tooth in the oral cavity.  A modified Pasteur pipette served as a chamber where the glass 
beads were then placed.  The inflow and outflow of media from rubber tubings 
connected to and from the chamber mimics the inflow and outflow of saliva in the oral 
cavity. The flow rate of the media was controlled at 0.3 mL min
-1
 using a peristaltic 
pump (Econo Pump, Bio Rad).  Following the inoculation of 20 mL of 10
6
 cell mL
-1
 of 
C. krusei suspension, the artificial mouth system was run overnight.  The glass beads 
were asceptically removed and immersed in separate appendorf vials containing 1 mL 
of PBS.  Each of the vials was placed in a sonicator for 60 seconds to dislodge the 
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adhered cells.  The population of the adhered cells was determined by plating 100 µL of 
the suspension obtained on YEPD agar plates.  The total CFU/mL following a 24 hours 
incubation period at 37°C was determined and recorded.  This procedure was followed 
closely to the steps outlined by Wan Nordini Hasnor (2007).  Similar procedure was 
repeated on the 1
st
 to 4
th
 switched generations of cells. 
 
3.2.9 Antifungal response of Candida krusei 
3.2.9.1 Preparation of aqueous plant extracts (Fathilah, 2004) 
3.2.9.1.1  Piper betle aqueous extract 
 Piper betle leaves were cleaned and the wet weight was taken.  The leaves were 
oven dried at 60 ºC for approximately 24 to 48 hours.  The dried leaves were weighed 
and recorded.  100 g of the leaves were cut into small pieces and put into a conical 
flask.  2 L of distilled water were added and boiled until the volume was reduced to 
half.  Later, the decoction was filtered into a 500 mL beaker.  The filtrate was re-boiled 
until it was concentrated to a final volume of 100 mL.  Finally, the concentrated extract 
was freeze dried to produce Piper betle extract powder and kept in a dry cabinet in 30% 
relative humidity (RH). 
 
3.2.9.1.2  Nigella sativa aqueous extract 
 100 g of Nigella sativa seeds were cleaned and put in 2 L of distilled water.  The 
suspension of the mixture was boiled until the volume reduced to half.  Next, filter 
paper was used to separate debris.  The filtrate was transferred into a 500 mL beaker.  
The suspension was reboiled until it reached a final volume of 100 mL.  The suspension 
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was freeze dried to produce Nigella sativa extract powder and kept in dry cabinet at 
30% relative humidity (RH). 
 
3.2.9.2  Susceptibility analysis 
The susceptibility of C. krusei to CHX was determined following two methods; 
the Kirby-Bauer disc diffusion test and broth dilution methods (Cappucino and 
Sherman, 2005).  According to the standard procedure of the Clinical and Laboratory 
Standards Institute (CLSI), C. krusei suspension can be prepared by suspending 1 to 2 
colonies of C. krusei grown on YEPD agar into 5 mL of 0.85% of sterile saline.  The 
optical density of the cell suspension was then standardised to an OD of 0.144 at 550 
nm wavelength.  100 µL of the suspension was pipetted out and evenly swabbed on 
Mueller-Hinton (MH) agar (BD, USA).  Paper discs which have been impregnated with 
120 µg (100 µL of 0.12%) CHX were carefully placed on to the swabbed MH agar 
plate. The diameter of an inhibited growth zone surrounding the discs following an 
overnight incubation at 37°C was then measured.  On the same plate, discs incorporated 
with 25 µg fluconazole and 1 µg voriconazole were used as the positive and negative 
control, respectively.  The susceptibility of Candida krusei to other antifungal agents 
including amphotericin B (25 µg), nystatin (100 µg), Piper betle (1 mg) and Nigella 
sativa (2 mg).  The susceptibility of all switched cells towards these agents were also 
determined and compared to the responses of the unswitched Candida krusei. 
 
3.2.9.3  Determination of the minimal inhibitory concentration (MIC)  
 The MIC of CHX was determined using the broth microdilution method 
(Cappucino and Sherman, 2005).  A sterile 96-well microtiter plate was labelled W1 to 
W7 horizontally and samples number vertically.  Using a sterile pipette, 100 µL of 
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YEPD broth was added to W2 through W7 while 100 µL of CHX (0.12%) was added 
into W1 and W2.  The plate was slowly agitated to mix the content.  Using a sterile 
pipette, 100 µL of W2 was transferred to W3. Following thorough mixing, 100 µL of 
W3 was transferred to W4 and the procedure was continued through W6.  After mixing, 
100 µL from W6 was discarded.  W7 that received no CHX and W1 that has no 
Candida krusei served as negative and positive control respectively for the experiment. 
Lastly, 100 µL of Candida krusei suspension was added to W2 through W7 aseptically.  
W7 that received no CHX served as a positive control.  The plate was incubated 
overnight at 37 ºC.  The concentration of CHX in the well that showed no turbidity was 
taken as the MIC of CHX towards Candida krusei.  The MIC‟s of Candida krusei in the 
unswitched and all switched generations to all other agents including amphotericin B, 
nystatin, Piper betle and Nigella sativa were also determined. 
 
3.2.9.4  Determination of the minimal fungicidal concentration (MFC)  
The minimal fungicidal concentration (MFC) of CHX was determined following 
the method described by Cappucino and Sherman (2005).   MFC is referred as the 
minimum fungicidal concentration at which 99% to 99.5% Candida krusei is killed.  
This value was determined by inoculating 100 µL from the well of the previous 
microtiter plate representing MIC on to YEPD agar plates respectively in triplicate.  The 
suspension was spread evenly on the agar surface and incubated for 18 to 24 hours at 37 
ºC.   Following incubation, the concentration from the plate which showed no growth of 
Candida krusei was considered as the MFC concentration of CHX towards Candida 
krusei.  The MFC‟s of amphotericin B, nystatin, Piper betle and Nigella sativa were 
determined following the same procedure. 
 
51 
 
3.2.9.5  Determination on the effect of CHX, Amphotericin B and Piper betle 
aqueous extract on the growth curve of phenotype-switched Candida krusei  
The effect of the respective antifungal agents on the growth curves of Candida 
krusei was performed by monitoring the growth of the cells in a growth condition which 
have been treated with the agents.  Five sterilized Schott bottles were labeled with 
unswitched (U), 1
st
 switched generation (S1), 2
nd
 switched generation (S2), 3
rd
 switched 
generation (S3) and 4
th
 switched generation (S4) of Candida krusei respectively.  40 mL 
of YEPD broth and 5mL of CHX stock (2 mg/mL) were added to each of the labeled 
Schott bottle to give a final concentration of 0.2 mg/mL (sub-MIC of CHX).  Following 
this, 5 mL of each generation of Candida krusei (10
6
 cell mL
-1
) was then added 
respectively into each of the Schott bottle according to the indicated labeled on the 
bottle to give a total volume of 50 mL.  The experiment was carried out in triplicates.  
The suspension was vortexed vigorously for 30 seconds and the initial absorbance was 
taken at OD550nm.  The suspension was then incubated in a shaking water bath at 37 ºC.  
The changes in OD of the growth suspension were recorded using spectrophotometer at 
every one hour interval. A graph of increase in cell population against growth time was 
plotted.  The experiment was stopped when the stationary phase was achieved. 
  
Similar protocol was repeated to determine the effect of the agents on the 
growth process of the 1
st
 to the 4
th
 switched cells with amphotericin B (250 µg/mL) and 
Piper betle (60 mg/mL) by replacing the CHX (2 mg/mL).  The final concentration of 
amphotericin B and Piper betle aqueous extract at sub-MIC value of amphotericin B 
(25 µg/mL) and Piper betle (6 mg/mL) were used in the experiment.  
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The growth rate constant (GR) and the generation time (GT) of Candida krusei 
was finally calculated using the formula below: 
 
 GR =  [(log10Nt2 – log10Nt1)2.303] / (t2-t1); t2>t1 
 GT =  (log10Nt2 – log10Nt1) / log102   
 
Nt1 = initial concentration                                       
Nt2 = final concentration 
t1  = initial time 
t2  = final time 
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4.0 RESULTS 
4.1 Biological characteristics of Candida krusei 
4.1.1 Colony morphology  
Sub-culturing of Candida krusei on YEPD agar was observed to produce colony 
with undulate margins, circular forms and umbonate elevation.  The surface appearance 
of the unswitched Candida krusei was observed as dry and round surfaces with white to 
cream colour.  The nitrogen depleted growth environment induced by the addition of 
Phloxine B had caused variations in the colony characteristics (Table 4.1, Figure 4.1). 
The 1
st
 and 2
nd
 switched generations were observed to have colonies with undulate 
margin, circular form and umbonate elevation which were similar to the morphological 
characteristics of the unswitched Candida krusei.  The surface appearance of Candida 
krusei in the 1
st
 and 2
nd
 generations was observed as wrinkled appearance which was 
absent in the unswitched Candida krusei.  The 3
rd
 switched generation showed different 
colony morphology with heavily wrinkled, myceliated surface appearance, lobate 
margin, irregular form and umbonate elevation.  The 4
th
 switched generation exhibited 
similar surface appearance and elevation compared to the 3
rd
 switched generation 
except for the filamentous margin and circular form.  
 
The ability of Candida krusei to utilise chromogenic substrate and developing 
colourised colony was determined by CHROMagar.  This study has observed that all 
colonies of unswitched and switched generations of Candida krusei grown on 
CHROMagar exhibited pink colour colonies with pale border, dry and rough surface 
appearances, undulate margin, circular form and umbonate elevation.   
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4.1.2 Recovery population of phenotypic switched Candida krusei 
Comparative to the unswitched Candida krusei, the recovery population in terms 
of CFU/mL showed that the 3
rd
 switched generation has the highest population recovery 
of 85.7% followed by the 4
th
 generation at 70.8% and 46.6% for the 1
st
 switched 
generation.  The 2
nd
 switched generation recovered the lowest population of only 36.4% 
(Table 4.1). 
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Figure 4.1:  Colony morphology of the unswitched and switched Candida krusei. (A) 
Unswitched, (B) 1
st
 switched generation, (C) 2
nd
 switched generation, (D) 3
rd
 switched 
generation and (E) 4
th
 switched generation.   
 
A 
B C 
D E 
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Table 4.1:  The characteristics of growth colonies of the unswitched and all switched 
generations of Candida krusei.  Note: The terminologies used were according to 
Samaranayake et al. (1994), Vargas et al. (2004) and Cappucino and Sherman (2005). 
Growth 
generation 
Colony characteristics Percentage 
of 
Recovered 
Population 
(%) 
Surface 
Appearance 
Margins Forms Elevation 
Unswitched 
Dry and 
rough 
Undulate Circular Umbonate 100.0 
1
st 
switched Dry, rough 
and wrinkled 
Undulate Circular Umbonate 46.6 
2
nd
 switched Dry, rough 
and wrinkled 
Undulate Circular Umbonate 36.4 
3
rd
 switched Dry, rough, 
heavily 
wrinkled and 
myceliated 
Lobate Irregular Umbonate 85.7 
4
th
 switched Dry, rough, 
heavily 
wrinkled and 
myceliated 
Filamentous Circular Umbonate 70.8 
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4.1.3 Biochemical validation of Candida krusei 
API 20 C AUX identification system was used to determine on the ability of 
Candida krusei to utilise substrates as a source of carbon.  Results obtained indicated 
that the unswitched and all switched generations of Candida krusei were able to ferment 
only glucose (Figure 4.2).  The BIOLOG identification system used in the study was 
based on the principle of substrate-enzyme interactions.  The unswitched and all 
switched generations of Candida krusei were shown to be able to ferment N-acetyl-D-
glucosamine and α-D-glucose.  Except for the unswitched and 1st generation which also 
fermented γ-aminobutyric acid (GABA), the 2nd, 3rd and 4th switched generations 
responded negatively towards the fermentation of γ-aminobutyric acid. 
 
 
Figure 4.2:  Biochemical test using API 20 C AUX.  Candida krusei was shown to 
positively fermented glucose as indicated by the hazy lines in the well within the yellow 
box. 
 
4.1.4 Cell morphology of Candida krusei 
Examination of prepared slides under 100 x magnification using light 
microscope following simple staining showed that the cells of the unswitched and 
switched Candida krusei have pseudohyphae (Figure 4.3).  Blastoconidia were present 
and observed as oval to elongated shape with the presence of verticillate branches. 
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Figure 4.3: Unswitched and switched Candida krusei examined at 100 x magnification 
using a light microscope; (A) unswitched, (B) 1
st
 switched generation, (C) 2
nd
 switched 
generation, (D) 3
rd
 switched generation and (E) 4
th
 switched generation. 
 
4.1.5 Ultrastructural characteristics of Candida krusei 
Scanning electron micrographs of the unswitched and all switched generations 
of C. krusei were observed as branched cells with elongated pseudohyphae and 
elongated to ovoidal blastoconidia and budding off in verticillate branch.  The surface 
appearance of the pseudohyphae was observed as smooth for the unswitched, 1
st
 and 2
nd
 
B 
C D 
A 
E 
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generations.  However, the 3
rd
 and 4
th
 switched generations had exhibited changes on 
the cell surface showing rough texture instead.  In contrast to other switched 
generations, the 4
th
 generation was observed to exhibit pimpled or punctate appearance 
on the cell surface (Soll, 1992).   The dimension of the 1
st
 switched generation 
pseudohyphae was found to be approximately 5.0-11.0 x 3.0-4.0 µm whereby the 
pseudohyphae of the 2
nd
 switched generation was identified to be the most extended 
compared to other generations with dimension of 5.0-15.0 x 2.0-4.0 µm.  The size of 
pseudohyphae of the 3
rd
 switched generation was determined as approximately 3.0-7.0 x 
2.0-3.0 µm.  The smallest pseudohypae was observed in the 4
th
 switched generation 
with size ranging approximately 2.0-6.0 x 2.0-5.0 µm.  In addition, the unswitched and 
the 3
rd
 switched generations were observed to develop extracellular matrix which was 
absent in the 1
st
, 2
nd
 and 4
th
 switched generations (Figure 4.4). 
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Figure 4.4: SEM micrographs of Candida krusei observed for the various growth 
generations. (A) unswitched, (B) 1
st
 switched generation, (C) 2
nd
 switched generation, 
(D) 3
rd
 switched generation and (E) 4
th
 switched generation (x 2000).  Note: (A1) 
Blastoconidia (A2) Pseudohyphae (A3) Extracellular matrix.   
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4.1.6 Growth curves of Candida krusei 
 Figure 4.5 showed the growth curves plotted from the study.  Descriptively, the 
growth curves of the unswitched and all switched generations showed no significant 
difference between all generations (p>0.05).  However, slight deviations of growth 
curves were observed among the generations.  The early log phase of the unswitched 
and all switched generations of Candida krusei were determined at three hours and the 
middle of the log phase were achieved after seven hours of incubation.  
 
 The specific growth rate (GR) of Candida krusei was found to differ in 
unswitched and all switched generations (Table 4.4).  In the unswitched state, the GR of 
Candida krusei was determined at 0.677 ± 0.021 h
-1
.  A slight decreased in GR was 
observed in the 1
st
 switched generation to 0.648 ± 0.131 h
-1 
and determined as the 
lowest GR among all generations of Candida krusei.  The 2
nd
 switched generation had 
showed an increased in the GR with 0.708 ± 0.021 h
-1 
which was also identified as the 
highest GR.  The GR was observed to decrease in the 3
rd
 (0.689 ± 0.132 h
-1
) and 4
th
 
switched generation (0.700 ± 0.100 h
-1
). 
 
Consequently, the generation time (GT) of all the respective curves also differ in 
the unswitched and all switched generations (Table 4.4).  In the unswitched state, the 
GT was determined at 3.905 ± 0.031 h.  A slight decreased in the GT was observed in 
the 1
st
 switched generation at 3.740 ± 0.101 h and determined as the lowest GT among 
generations of Candida krusei.  The 2
nd
 switched generation showed an increase in GT 
to 4.085 ± 0.001 h which was also identified as the highest GT.  The GT of the 3
rd
 
switched generation was 3.976 ± 0.102 h whereby the 4
th
 switched generation was 
4.041 ± 0.005 h. 
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Figure 4.5:  The growth curve (GC) of Candida krusei.  A comparison between 
unswitched and all switched generations in untreated environment. 
 
4.2 Adherence capacity of Candida krusei to saliva-coated glass surfaces 
The ability of Candida krusei to adhere to the surfaces of saliva-coated glass 
beads was recorded at (5.62 ± 2.95) x 10
2
 CFU/mL.  Figure 4.6 showed an increase to 
(15.29 ± 10.32) x 10
2
 CFU/mL in the 1
st
 switched generation compared to the 
unswitched Candida krusei. A drastic increased in adherence capacity in the 2
nd
 
switched generation to (154.0 ± 60.2) x 10
2
 CFU/mL was observed.  However, the 
adherence capacity was reduced in the 3
rd
 and 4
th
 switched generations of Candida 
krusei to (18.76 ± 7.56) x 10
2
 CFU/mL and (9.38 ± 0.37) x 10
2
 CFU/mL, respectively. 
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Figure 4.6:  The adherence capacity of Candida krusei to saliva-coated glass surface.  
The values were means ± standard deviation (n=9). 
 
4.3 Antifungal responses of Candida krusei 
4.3.1 Disinfectant 
4.3.1.1 Susceptibility towards CHX 
The degree of susceptibility towards CHX was found to differ in the unswitched 
and all switched generations.  In the unswitched state, Candida krusei was found to be 
susceptible to CHX with a growth inhibition zone of 3.8 ± 0.1 cm and was the most 
susceptible towards CHX compared to other generations.  The degree of susceptibility 
was gradually decreased in the 1
st
 and the 2
nd
 switched generations with inhibition zone 
of 3.5 ± 0.2 cm and 3.0 ± 0.1 cm, respectively (Figure 4.7).  In the 3
rd
 and 4
th
 switched 
generations, susceptibility towards CHX was observed to increase gradually with 
inhibition zone of 3.4 ± 0.2 cm and 3.5 ± 0.1 cm, respectively.  The MIC and MFC of 
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Candida krusei at each switched generation were determined at 0.4 µg/µL (Table 4.2, 
Table 4.3). 
 
Figure 4.7:  The susceptibility of Candida krusei in the unswitched and switched forms 
towards CHX as determined using the disc diffusion method.  The values were means ± 
standard deviation (SD) (n=9). 
 
4.3.2 Chemical-based agents 
4.3.2.1 Susceptibility towards amphotericin B 
The susceptibility of the unswitched Candida krusei towards amphotericin B 
was recorded to have an inhibition zone diameter of 2.2 ± 0.1 cm.    The degree of 
susceptibility was gradually increased in the 1
st
, 2
nd
 and 3
rd
 switched generations with 
inhibition zone of 2.3 ± 0.3 cm, 2.4 ± 0.1 cm and 2.6 ± 0.3 cm, respectively with the 3
rd
 
switched generation was found to be the most susceptible towards amphotericin B 
(Figure 4.8).  The susceptibility was determined to decrease in the 4
th
 switched 
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generations with inhibition zone of 2.4 ± 0.1 cm.  The MIC and MFC of Candida krusei 
at each switched generation were determined at 10 µg/mL (Table 4.2, Table 4.3). 
 
Figure 4.8:  The susceptibility of Candida krusei in the unswitched and switched forms 
towards amphotericin B as determined using the disc diffusion method.  The values 
were means ± standard deviation (SD) (n=9). 
 
4.3.2.2 Susceptibility towards nystatin 
The susceptibility of unswitched Candida krusei towards nystatin was recorded 
to have an inhibition zone of 2.4 ± 0.1 cm.  The degree of susceptibility remained 
unchanged in the 1
st
 switched generation.  However, the susceptibility was decreased in 
the 2
nd
 switched generation with inhibition zone of 1.9 ± 0.2 cm respectively (Figure 
4.9) and identified as the least susceptible towards nystatin.  In the 3
rd
 and 4
th
 switched 
generations, the susceptibility towards nystatin was observed to increase gradually with 
inhibition zones of 2.3 ± 0.1 cm and 2.6 ± 0.1 cm respectively.  The 4
th
 switched 
generation was determined as the most susceptible among generations of Candida 
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krusei.  The MIC and MFC of Candida krusei at each switched generation were 
determined at 50 unit/mL (Table 4.2, Table 4.3). 
 
Figure 4.9:  The susceptibility of Candida krusei in the unswitched and switched forms 
towards nystatin as determined using the disc diffusion method.  The values were means 
± standard deviation (SD) (n=9). 
 
4.3.3 Plant-based agents 
4.3.3.1 Susceptibility towards Piper betle aqueous extract 
The degree of susceptibility towards Piper betle aqueous extract was found to 
differ in unswitched and all switched generations.  In the unswitched state, Candida 
krusei was found to be susceptible to Piper betle aqueous extract with inhibition zone 
diameter of 2.2 ± 0.1 cm.  Differently for the 1
st
 switched generation where the degree 
of susceptibility was found to increased with inhibition zone diameter of 2.3 ± 0.2 cm 
(Figure 4.10).   The susceptibility of Candida krusei towards Piper betle aqueous 
extract was identified to decrease in the 2
nd
 switched generation with 2.1 ± 0.1 cm 
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inhibited zone.  The susceptibility in the 3
rd
 switched generation remains unchanged 
with inhibition zone of 2.1 ± 0.2 cm.  The 4
th
 switched generation was found to have a 
lowered susceptibility compared to the 2
nd
 and 3
rd
 generations with inhibition zone of 
2.0 ± 0.2 cm which was the least susceptible towards Piper betle aqueous extract among 
generations of Candida krusei.  The MIC and MFC towards Piper betle aqueous extract 
were determined at 12.5 mg/mL for unswitched and all switched generations of 
Candida krusei (Table 4.2, Table 4.3). 
 
Figure 4.10:  The susceptibility of Candida krusei in unswitched and switched forms 
towards Piper betle aqueous extract as determined using the disc diffusion method.  The 
values were means ± standard deviation (SD) (n=9). 
 
4.3.3.2 Susceptibility towards Nigella sativa aqueous extract 
From the analysis, all generations of Candida krusei were found to be resistant 
to Nigella sativa aqueous extract (Table 4.2). 
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Table 4.2:  The effect of phenotypic switching on the susceptibility of Candida krusei towards CHX, amphotericin B, nystatin, Piper 
betle and Nigella sativa aqueous extract.  (R) is referred to resistance.  The inhibition zones were the mean ± standard deviation (SD) 
with n=9. Note: Concentration of CHX is dependent to the concentration used in commercialized product.  The concentration of 
amphotericin B and Piper betle are dependent to the concentration used in the determination of susceptibility by CLSI whereby the 
concentration of Piper betle is standardize to the concentration used in the determination of susceptibility of Candida krusei towards 
Nigella sativa. 
Type of 
antimicrobial 
agents 
Active 
ingredients 
Concentration 
Growth generations 
Unswitched 1
st
 switched 2
nd
 switched 3
rd
 switched 4
th
 switched 
Inhibition zone (cm) 
Disinfectant CHX 1.2 µg/µL 3.8 ± 0.1 3.5 ± 0.2 3.0 ± 0.1 3.4 ± 0.2 3.5 ± 0.1 
Chemical 
based 
Amphotericin B 100 µg/mL 2.2 ± 0.1 2.3 ± 0.3 2.4 ± 0.1 2.6 ± 0.3 2.4 ± 0.1 
Nystatin 250 unit/mL 2.4 ± 0.1 2.4 ± 0.1 1.9 ± 0.2 2.3 ± 0.1 2.6 ± 0.1 
Plant based 
Piper betle 200 mg/mL 2.2 ± 0.1 2.3 ± 0.2 2.1 ± 0.1 2.1 ± 0.2 2.0 ± 0.2 
Nigella sativa >200 mg/mL R R R R R 
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Table 4.3: The MIC and MFC of CHX, amphotericin B, nystatin, Piper betle and Nigella sativa aqueous extract towards the 
unswitched and all switched generations of Candida krusei (n=9). 
Growth 
generations 
CHX 
(µg/µL) 
Amphotericin B 
(µg/mL) 
Nystatin 
(unit/mL) 
Piper betle 
(mg/mL) 
Nigella sativa 
(mg/mL) 
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
Unswitched 0.4 0.4 50 50 10 10 12.5 12.5 >200 >200 
1
st
 switched 0.4 0.4 50 50 10 10 12.5 12.5 >200 >200 
2
nd
 switched 0.4 0.4 50 50 10 10 12.5 12.5 >200 >200 
3
rd
 switched 0.4 0.4 50 50 10 10 12.5 12.5 >200 >200 
4
th
 switched 0.4 0.4 50 50 10 10 12.5 12.5 >200 >200 
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4.4 Growth curves of unswitched and switched generations of Candida krusei 
under treated environment 
4.4.1 Disinfectant 
4.4.1.1 Chlorhexidine (CHX)  
Figure 4.11 showed the various growth curves plotted from the study.  The 
growth curves of the unswitched and all switched generations have showed no 
significant difference among generations.  However, slight deviations of growth curve 
were observed among the generations.  The early log phase of unswitched and all 
switched generations of Candida krusei were determined at one hour incubation 
whereby the middle log phase were observed at  5.5 hours of incubation. 
 
The specific growth rate (GR) of CHX treated Candida krusei was found to 
differ in unswitched and all switched generations.  In the unswitched state, the GR of 
Candida krusei was determined at 3.618 ± 0.051 h
-1
.  A gradual decreased in GR was 
observed in the 1
st
 and 2
nd
 switched generation with 0.597 ± 0.029 h
-1 
and 0.339 ± 0.004 
h
-1 
(43.2%) respectively.  The 2
nd
 switched generation was determined as the lowest GR 
among generations of Candida krusei.    However, the degree of GR was found to 
increase in the 3
rd
 switched generation with 0.592 ± 0.022 h
-1
.   A slight decreased in 
GR was determined in the 4
th
 switched generation with 0.566 ± 0.022 h
-1
. 
 
Consequently, the generation time (GT) of CHX treated Candida krusei was 
also identified to differ in unswitched and all switched generations.  In the unswitched 
state, the GT of Candida krusei was determined at 3.566 ± 0.031 h.  A slight decreased 
in GT was observed in the 1
st
 and 2
nd
 switched generation with 3.444 ± 0.035 h
 
and 
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1.953 ± 0.028 h
 
respectively with the 2
nd
 switched generation was determined as the 
lowest GT among generations of Candida krusei.   The degree of GT was found to 
increase in the 3
rd
 switched generation with 3.414 ± 0.022 h.  However, the 4
th
 switched 
generation was observed to encounter a slight decrease in GT with 3.267 ± 0.025 h. 
 
Table 4.4 and figure 4.14 showed the GR and GT of unswitched and all 
switched generations of Candida krusei were decreased.  Among the generations, 2
nd
 
switched generations were observed to be the most influence in CHX growth condition 
with 52.1% reduction in GR.  Whereby, the 1
st
 switched generation was observed to be 
the least influence by 7.9% reduction.  These are similar to the GT where the most 
influence generation was determine at the 2
nd
 switched generation whereas the least 
influenced was the 1
st
 switched generation with 52.2% and 7.9% GT reduction 
respectively. 
 
Figure 4.11:  The growth curve (GC) of Candida krusei.  A comparison between 
unswitched and all switched generations in CHX treated environment. 
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4.4.2 Chemical-based agent 
4.4.2.1 Amphotericin B  
Figure 4.12 showed the various growth curves plotted from the study.  The 
growth curves of the unswitched and all switched generations showed no significant 
difference among all generations (p>0.05).  Slight changes in the deviation of growth 
curve were observed among the generations.  The early log phase of unswitched and all 
switched generations of Candida krusei were determined at one hour incubation 
whereby the middle of the log phase were achieved after five hours incubation. 
 
The growth rate (GR) of amphotericin B treated Candida krusei was found to 
differ in unswitched and all switched generations.  The GR of Candida krusei was 
determined at 0.585 ± 0.013 h
-1 
in unswitched stage.  An increased in GR was observed 
in the 1
st
 switched generation with 0.631 ± 0.014 h
-1 
and determined as the highest 
among generations.  Following that, a decreasing in GR were observed in the 2
nd
 and 3
rd
 
switched generations with GR of 0.585 ± 0.017 h
-1 
and 0.556 ± 0.021 h
-1 
respectively.  
However, the 4
th
 switched generation was observed to have an increased in GR with 
0.606 ± 0.010 h
-1
. 
 
Consequently, the generation time (GT) of amphotericin B treated Candida 
krusei was also identified to differ in unswitched and all switched generations.  In the 
unswitched state, the GT of Candida krusei was determined at 3.378 ± 0.051 h.  An 
increased in GT was observed in the 1
st
 switched generation with 3.643 ± 0.042 h
 
and 
determined as the highest GT among the generations.  A decreased in GT was identified 
in the 2
nd
 switched generation to 3.377 ± 0.054 h whereby the lowest GT was observed 
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in the 3
rd
 switched generation with 3.208 ± 0.073 h.  However, the GT was found to 
increase in the 4
th
 switched generation with 3.498 ± 0.081 h. 
 
Table 4.4 and figure 4.14 showed the GR and GT of unswitched and all 
switched generations of Candida krusei were decreased.  Among the generations, 3
rd
 
switched generations were observed to be the most influenced in amphotericin B growth 
condition with 19.3% reduction in GR.  Whereby, the 1
st
 switched generation was 
observed to be the least influence by 2.6% reduction.  These are similar to the GT where 
the most influence generation was determine at the 3
rd
 switched generation whereas the 
least influenced was the 1
st
 switched generation with 19.3% and 2.6% GT reduction 
respectively. 
 
Figure 4.12:  The growth curve (GC) of Candida krusei.  A comparison between 
unswitched and all switched generations in amphotericin B treated environment. 
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4.4.3 Plant-based extract 
4.4.3.1 Piper betle aqueous extract  
Figure 4.13 showed the various growth curves plotted from the study.  The 
growth curves of the unswitched and all switched generations has no significant 
difference among all generations (p>0.05).  However, slight deviations of growth curve 
were observed among the generations.  The early log phase of unswitched and all 
switched generations of Candida krusei were determined at one hour incubation 
whereby the middle of the log phase were achieved after seven hours incubation. 
 
The growth rate (GR) of Piper betle treated Candida krusei was found to differ 
in unswitched and all switched generations.  In the unswitched state, the GR of Candida 
krusei was determined at 0.560 ± 0.044 h
-1
.  A drastic decreased of GR was observed in 
the 1
st
 switched generation with 0.387 ± 0.053 h
-1 
(30.9%) and was the lowest GR 
among generations of Candida krusei (Figure 4.20).  However, the 2
nd
 switched 
generation has showed an increased in GR with 0.507 ± 0.031 h
-1 
(31%) followed by 3
rd
 
and 4
th
 switched generations with GR 0.532 ± 0.032 h
-1
 (4.9%) and 0.586 ± 0.132 h
-1
 
(10.2%) respectively.   The GR of the 4
th
 switched generation was determined as the 
highest among unswitched and switched generations of Candida krusei. 
 
The generation time (GT) of Piper betle treated Candida krusei was also 
identified to differ in unswitched and all switched generations.  In the unswitched state, 
the GT of Candida krusei was determined at 3.233 ± 0.321 h.  The GT was observed to 
decreased in the 1
st
 switched generation with 2.235 ± 0.231 h and determined as the 
lowest GT between generations.  The 2
nd
 switched generation showed an increased in 
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GT with 2.923 ± 0.221 h
 
followed by the 3
rd
 and 4
th
 switched generations with GR 
3.069 ± 0.234 h and 3.382 ± 0.312 h respectively.  The 4
th
 switched generation was 
determined as the highest GT among unswitched and all switched generations of 
Candida krusei. 
 
Table 4.4 and figure 4.14 showed the GR and GT of unswitched and all 
switched generations of Candida krusei were decreased.  Among the generations, 1
st
 
switched generation was observed to be the most influence in Piper betle growth 
condition with 43.4% reduction in GR.  Whereby, the 4
th
 switched generation was 
observed to be the least influenced by 16.3% reduction.  These are similar to the GT 
where the most influenced generation was determine at the 3
rd
 switched generation 
whereas the least influenced was the 1
st
 switched generation with 40.2% and 16.3% GT 
reduction respectively. 
 
Figure 4.13:  The growth curve (GC) of Candida krusei.  A comparison between 
unswitched and all switched generations in Piper betle aqueous extract treated 
environment. 
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Figure 4.14:  The growth curve (GC) of unswitched and switched Candida krusei of 
untreated (        ), CHX (        ), amphotericin B (        ) and Piper betle (         ) treated 
growth environment.   
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Table 4.4:  The changes in the generation times (GT) and specific growth rate (GR) of unswitched and all switched generations of 
Candida krusei when their growth were perturbed with the introduction of CHX, amphotericin B and Piper betle.  The concentrations 
used in the study were dependent to the concentration of sub-MIC.  
Growth conditions growth rate (GR) 
and Generation times 
(GT)  
Growth generations 
Unswitched 1
st
 switched 2
nd
 switched 3
rd
 switched 4
th
 switched 
Untreated 
GR (h
-1
) 0.677 ± 0.021 0.648 ± 0.131 0.708 ± 0.021 0.689 ± 0.132 0.700 ± 0.100 
GT (h) 3.905 ± 0.031 3.740 ± 0.101 4.085 ± 0.001 3.976 ± 0.102 4.041 ± 0.005 
CHX 
GR (h
-1
) 0.618 ± 0.051 0.597 ± 0.029 0.339 ± 0.004 0.592 ± 0.022 0.566 ± 0.022 
GT (h) 3.566 ± 0.031 3.444 ± 0.035 1.953 ± 0.028 3.414 ± 0.022 3.267 ± 0.025 
Amphotericin B 
GR (h
-1
) 0.585 ± 0.013 0.631 ± 0.014 0.585 ± 0.017 0.556 ± 0.021 0.606 ± 0.010 
GT (h) 3.378 ± 0.051 3.643 ± 0.042 3.377 ± 0.054 3.208 ± 0.073 3.498 ± 0.081 
Piper betle 
GR (h
-1
) 0.560 ± 0.044 0.387 ± 0.053 0.507 ± 0.031 0.532 ± 0.032 0.586 ± 0.132 
GT (h) 3.233 ± 0.321 2.235 ± 0.231 2.923 ± 0.221 3.069 ± 0.234 3.382 ± 0.312 
The values were the mean ± standard deviation (SD) of triplicates from three determinations (n=9).
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5.0 DISCUSSION 
In this study, phenotypic switching of Candida krusei was induced by the 
addition of phloxine B (tetrabromotetrachlorofluorescein) which acts as switching 
detecting agent for Candida sp.  The addition of phloxine B in the media has created a 
nitrogen suppressed growth condition for Candida krusei (Coote, 2001).  The chemical 
compounds in Phloxine B dye have been shown able to facilitate the detection of mutant 
yeast that lack the capability synthesizing purine and pyramidine bases or amino acids.  
It has also been reported that phloxine B is not a growth inhibitor, but it promotes death 
of candidal yeast under nitrogen limitation conditions (Middelhoven et al., 1976). Thus, 
the application of phloxine B in the growth environment had caused Candida krusei 
cells to switch in order to overcome the killing factors provided by the dye.   
 
Candida krusei in this study exhibited characteristic of cream to whitish colour, 
dry and rough surface appearance with undulate margin, circular forms and umbonate 
elevation when cultured on YEPD agar.  Samaranayake and Samaranayake (1994) had 
earlier described the colony morphology of Candida krusei as matt, rough surface 
appearance with cream to whitish colour on SDA.  Both observations did not conform 
to the characteristics given in the ATCC manual which described Candida krusei as 
butyrous surface with entire margin on SDA.  Variations in the colony characteristics 
may be due to the different growth medium used.  This may affect the development of 
colony morphology of Candida krusei.  YEPD agar is a medium containing rich mineral 
of zinc and able to suppress the expression of phenotype.  Nevertheless, it does not 
influence the switching system of Candida sp. (Odds et al., 1989) and therefore the 
usage of YEPD in the study did not interfere with the phenotypic switching 
determination. 
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The colony morphology in each generation of switched Candida krusei was 
observed different in terms of surface appearance, margin, form and elevation.  This 
finding was similar to the reports on Candida albicans and Candida glabrata where 
various colony morphology phenotypes were observed at different growth generations 
including smooth, myceliated and wrinkled surface appearance (Vargas et al., 2004).  In 
our study, we had observed the transition in the colony morphology characteristics 
between the 2
nd
 and 3
rd
 switched generations which are similar to the reported findings 
on Candida albicans which showed to exhibit predominant transition between 
unmyceliated to myceliated colony (Soll et al., 1987). Phenotypic switching 
phenomenon could also occur after a prolonged incubation (Slutsky et al., 1985; Slutsky 
et al., 1987) which may enhance the development of different colony morphology of 
Candida krusei.  These different switched phenotypes act as a survival strategy of 
Candida krusei, as different phenotype serve a different role in providing adaptability 
and survivability at different condition (Soll, 1992). 
 
CHROMagar is a chromogenic medium which is widely used in the 
identification and detection of yeasts including Candida krusei (Hospenthal et al., 
2006).  The superiority to inhibit the growth of bacterial strains was determined to be 
higher compared to SDA which is generally used in the identification of candidal 
species (Sivakumar et al., 2009).  From the study, the colonies of Candida krusei were 
determined to grow pink in colour with pale border, dry and rough surface appearances, 
undulate margin, circular form and umbonate elevation which are similar to the finding 
by Hospenthal et al. (2002).  The colourization of the colony is due to the reaction of 
specific enzymes produced by Candida krusei towards chromogenic substrates yielding 
microbial colonies expressing specific pigmentation, hence allowing the confirmation of 
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the species by the detection of colour and colony morphology of the candidal strains 
(Sivakumar et al., 2009).    
 
The recovery population determined the sustainability of each switched 
generation of Candida krusei under suppressed growth environment.  In our study, the 
recovery population of the 3
rd
 switched generation was found to be the highest 
recovered at 85.7% followed by the 4
th
 generation at 70.8%.  1
st
 switched generation 
was identified to have recovery percentage of 46.6% and the 2
nd
 switched generation 
was determined to have the least recovery population with only 36.4%.  The difference 
on the recovery population was suggested to occur due to the different phenotype 
plasticity among switched generations.  Similar findings on the various population 
recovery was reported where different switched generations possessed different 
percentage recovery population, thus, suggested that different generations represent 
different survival ability and stability due to the suppressed environment (Lackhe et al., 
2000). 
 
From the study, the unswitched and all switched generations of Candida krusei 
were identified to ferment only glucose out of 19 other substrates including glucose, 
glycerol, 2-keto-D-gluconate, L-arabinosa, D-xylose, adonitol, xylitol, galactose, 
inostol, sorbitol, α-methyl-D-glucoside, N-acetyle-D-glucosamine, cellobiose, lactose, 
maltose, sucrose, trehalose, melezitose and raffinose.  According to Melville and 
Russells (1975), Candida krusei can ferment dextrose, producing acid and gas.  This 
phenomenon was reported similar with the finding by Samaranayake and Samaranayake 
(1994) where Candida krusei was reported to ferment only glucose out of a large panel 
of carbohydrates.  The unswitched and all switched Candida krusei were observed 
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fermenting N-acetyl-D-glucosamine (C8H15NO6) as a carbon source.  This may suggest 
that all generations of Candida krusei are able to ferment N-acetyl-D-glucosamine 
which is a derivative of the monosaccharide glucose.  Candida krusei was also 
determined as a pathogenic microorganism which is able to grow in vitamin-free media 
(Odds, 1988).  From the study, γ-aminobutyric acid (GABA) was found to be one of the 
nutrient sources for the unswitched and 1
st
 switched generations of Candida krusei.  
According to Kumar and Punekar (1997), most yeasts and fungi utilise GABA as a 
source of carbon and nitrogen.  This substrate was identified as an important agent 
which associate to the sporulation and spore metabolism of the yeast.  Information on 
the role of GABA in fungal biology is gradually increasing.   
 
Based on light microscope observation, in general Candida krusei forms 
elongated pseudohyphae with elongated to ovoidal blastoconidia and budding off 
verticillate branch.  These characteristics conform to the description on cellular 
characteristics of Candida krusei by Samaranayake and Samaranayake (1994).  Candida 
krusei was also described in the ATCC manual as „long grain rice‟ shaped yeast with 
branched pseudohyphae and elongated blastoconidia.   
 
However, based on SEM micrograph, some variations in the cell morphology 
characteristics were observed throughout different switched generations, which could 
occurred due to some environmental constrains during the blastoconidia-hyphae 
transitions. The transition of smooth to pimpled and punctate morphology in the 3
rd
 to 
the 4
th
 switched generation of Candida krusei observed in our study was similar to the 
response as the transition of white to opaque cell in Candida albicans switched 
generations.  According to Soll (1992), the formation of pimpled and punctate 
 82 
 
characteristic observed in the ultrastructure of candidal cells could be an outcome of 
blastoconidia and pseudohyphae maturity in each level of the switched generations.  In 
addition, the variant colony morphologies have been described in several reports to be 
dependent on the proportion and distribution of blastoconidia and pseudohyphae.  Their 
presence could have led to the changes in the colony morphology of the switched 
Candida krusei (Vargas et al., 2004). 
 
In the study, 2
nd
 switched generation of Candida krusei was identified to be 
more extended compared to other generation.  According to Anderson and Soll (1987), 
this extension which also occurs among switched Candida albicans is due to the 
distribution of actin granules which is mostly found on the apex of the pseudohyphae 
and the generations of various characteristics of pseudohyphae were dependent on the 
pattern of actin granule distribution between growing blastoconidia and pseudohyphae 
in the candidal strains. It is also suggested that the hyphae-specific genes may be 
transiently recruited among switched Candida krusei as an adaptation to the 
environmental changes which then led to the different dimension and size of the cell of 
Candida krusei.  Thus, hyphae-specific function and hyphae specific gene expression 
were identified to play an important role in generating unique phenotype at different 
switched generation of Candida krusei.   
 
From the susceptibility tests, all switched generations of Candida krusei were 
found to be susceptible to CHX.  According to several researches, CHX affects the 
plasma membrane of the candidal cell by non-specific binding to the negatively charged 
protein and phospholipid moieties of the cell wall.  This binding will then alter the 
cellular membrane structure and interfere with the cellular osmotic balance that lead to 
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the susceptibility of candidal strains (Freitas et al., 2003; Bonacorsi et al., 2004; 
Veerman et al., 2004) towards CHX.  In addition, this study demonstrated that the 
unswitched and all switched generations of Candida krusei were susceptible to 
amphotericin B.  According to Anil (2002) and Williams et al. (2011), amphotericin B 
is grouped as polyene which acts as a broad spectrum of fungicidal and fungistatic.  
This polyene affects the composition of the sterol on the cell wall of the target cells 
which then damage the cell walls.  The damaging caused potassium ions and glucose to 
be released out from the cell, disturbing the glycolysis which finally inhibits the growth 
of the candidal cells.  
 
The unswitched and all switched Candida krusei were found to be susceptible to 
nystatin.  This sensitivity occurred due to the mechanism of altering the cell 
permeability of candidal strains that induce cell porosity (Kerridge, 1986).  The 
interaction between nystatin and ergosterol component within the cell membrane 
influence the cell permeability due to the lost of cytoplasmic membrane which then lead 
to the mortality of Candida krusei (Williams et al., 2011).   
 
The study has shown that the unswitched and all switched Candida krusei were 
also susceptible to Piper betle aqueous extract.  Piper betle was classified as antifungal 
agents having the potential of damaging the cell membrane of the candidal species 
which lead to the lost of the cell viability and leakage of the intracellular constituents 
(Indu and Ng, 2002; Guha, 2006).  The active components such as hydroxichavicol, 
stearic acids and hydroxyl fatty acids esters has extensively reported as the antibacterial 
and antifungal agents and widely used in traditional therapeutic (Pauli et al., 2002; 
Nalina and Rahim, 2007). 
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In this study, some variations in the degree of susceptibility between the various 
switched generations displayed the responses of the switched cells to survive and attain 
overall fitness.  In other words, as described by Vargas (2004), when a cell undergo 
switching, many of its features such as cell physiology, antigenicity of the cell surface, 
the composition of its basic molecules like protein,  lipid  and sugar may be altered and 
stimulated in the attempt to achieve the best adaptability to the environmental constrain. 
 
All generations of Candida krusei in our study had shown the ability to adhere 
to the surfaces of saliva-coated glass beads.  This finding was reported by 
Samaranayake et al. (1994) as Candida krusei was found to adhere higher on inert 
surfaces compared to the buccal epithelial cells (BEC).  In addition, Candida krusei was 
also reported to exhibit high hydrophobicity ability which encouraged adherence.  The 
hydrophobicity of Candida krusei was identified to have 5-fold greater than Candida 
albicans (Samaranayake et al., 1994).  Nevertheless, our study had found that the 
adherence ability varied among switched generations of Candida krusei.  The adherence 
of all switched Candida krusei were found to be higher compared to the unswitched 
generation.   The 2
nd
 switched generation was determined to have the highest adherence 
ability followed by 3
rd
, 1
st
 and 4
th
 switched generation.  According to Jones et al. 
(1994), phenotype switched can change the ability of Candida sp. to attach to a surface.  
In addition, the type or form of hyphae following phenotypic switch has been found to 
influence the adherence of candidal cells to inert surfaces (Jones et al., 1994).  This 
might explain the highest adhering ability exhibited by the 2
nd
 switched generation cells 
(Anderson and Soll, 1987).  
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From the study, the unswitched and all switched generations of Candida krusei 
showed varying degrees of responses following exposure to antimicrobial agents.  The 
unswitched and all switched generations were observed to influence in antimicrobial 
presenting growth environment.  The reducing in GR and GT in all growth generations 
indicated that the microbial agents showed efficacy in the treatment of Candida krusei.  
These different responses in the growth activities were determined as an outcome of 
phenotypic switching.  Regulation of the growth activities could be an attempt to 
maintain the fitness of the cells to survive under adverse conditions (Vargas et al., 
2004).  According to Cowen et al. (2001), an observation on the ability of Candida 
albicans to adapt to the inhibitory concentration in fluconazole treated environment 
found that the strain was producing different genes expression that involve in drug 
resistance which then lead to the variability in the generation time (GT) of some isolates 
that had been generated from one progenitor which suggested similar response occurred 
in the phenotypic switching of Candida krusei presented in this study. 
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6.0 CONCLUSION 
This study has determined the phenotypic switching capability of Candida 
krusei which contributed to the changes in the biological characteristics as well as the 
adherence capacity towards hard surface. The various in responses among unswitched 
and switched Candida krusei towards CHX, nystatin, amphotericin B and plant extracts 
(Nigella sativa and Piper betle) indicated that the phenotypic switching affects the 
susceptibility of the candidal strains.  Thus, it is concluded that the phenotypic 
switching of Candida krusei leads to the pathogenic property in the oral cavity. 
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7.0 FUTURE STUDIES 
1) To determine the biological characteristics of phenotypic switched 
genetically Candida krusei. 
2) To determine specific genes which enhance the phenotypic switching 
properties of Candida krusei. 
3) To characterize mono-species biofilm (MSB) and dual-species biofilm 
(DSB) of phenotypic switched Candida krusei and non-krusei on denture 
acrylic surface. 
4) To determine the factors affecting biofilm formation of MSB and DSB of 
phenotypic switched Candida krusei and non-krusei. 
5) To evaluate the consequences of MSB and DSB of phenotypic switching 
Candida krusei and non-krusei on the susceptibility towards active 
component of Piper betle aqueous extract. 
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 to 
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APPENDIX 2 
Abstract. The 2
nd
 Thailand International Conference on Oral Biology, TiCOB, Thailand, 
2008. 
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th
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